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This randomized controlled experimental study was designed to determine 
whether Kinesiology, as an adjunct to medical therapy, would improve the 
management of patients with Crohn's disease. One hundred and fifty consecutive 
Crohn's disease patients, attending the Gastrointestinal Clinic at Groote Schuur 
Hospital, were randomly assigned to a Kinesiology (n=50) and a Control Group 
(n=50). In order to assess the effect of physical contact, a third group who 
received Massage (n=50), was also included. All participants attended their 
monthly hospital visits and continued taking their prescribed medication. In 
addition, the Kinesiology Group received a 60-minute Kinesiology session and 
the Massage Group a 60-minute massage session on a monthly basis for four 
months. 
Disease activity was assessed by means of the Crohn's Disease Activity Index 
(CDAI), quality of life by the Short Inflammatory Bowel Disease Questionnaire 
(SIBDQ) and psychological state by the Profile Of Mood States (POMS). 
Assessments were performed at entry into the study, following four months of 
therapy and again at three-month follow-up. At entry into the study, patients were 
assessed in accordance with their disease activity (Active-CDAI>200, Quiescent-
CDAI<150, Indeterminate-CDAI 150-200). At entry into the study, the three 
groups were equivalent in terms of demographics, haematology, biochemistry, 
disease activity, quality of life, and psychological mood states. 
Following a four-month intervention period for the patients with active disease: 
the Kinesiology Group demonstrated a Significant reduction in CDAI (p<0.001). 
This significant reduction was maintained at follow-up (p<0.001) whereas the 
Massage and Control Groups did not show any significant results. The 
Kinesiology Group also demonstrated a significant improvement in quality of life 
(SIBDQ) at follow-up (p<0.05) but not the Massage and Control Groups. 











improvement in the Kinesiology Group remained consistent throughout, 
compared to the Massage and Control Groups who deteriorated. For the patients 
with quiescent disease: Kinesiology was associated with maintenance of 
remission whereas the Control and the Massage Groups demonstrated 
deterioration at follow-up. This study demonstrates that Kinesiology has a 
beneficial adjunctive role in the management of patients with Grohn's disease, 













Grahn's disease is a chronic gastrointestinal disorder of unknown etiology 
(Gasellas et aI., 2000). Individuals with the disease may experience recurrent 
episodes of abdominal pain, diarrhea, fever, vomiting associated with weight 
loss, chronic gastrointestinal bleeding, anemia, and systemic manifestations 
(Garret, Brantley, Jones and McKnight, 1991). Grahn's disease can occur in any 
area of the gastrointestinal tract, from the mouth to the anus (Rosenberg et aI., 
1994). The clinical course of the disease is commonly marked by periods of 
remission and exacerbation. Approximately 25-50% relapse annually (Prantera 
et aI., 1996; Riley et aI., 1990). 
The incidence of Grohn's disease is around 1-6 per 100,000 and could be higher 
in females, by as much as 30% (Stenson, 1991). The peak age of onset is 
between the ages of 15 and 25 years. Another smaller peak also seems to occur 
between the ages of 55 and 65 years (Stenson, 1991). 
The prevalence of Grahn's disease has been reported to be around 10-100 per 
100,000 in the developed countries (Galkins et aI., 1996). Even though this 
prevalence may seem small, the cost of the disease is high. In a study 
undertaken in Sweden it was found that in 1994, the total cost of Grohn's disease 
calculated from hospital admissions, ambulatory care, drugs, sickness leave, and 
early retirement was US $43.1 ,million (Bernstein et aI., 2000). Two percent of all 
patients were responsible for 10% of the total admissions during 1994. This 
finding was similar to findings in the US~ and the UK. Drug therapy was 
responsible for only 6% of the total cost, whereas morbidity of the patients 











A recent study has reported that the average cost of care for Crohn's disease is 
approximately $12,500 per patient (Hewitt, 1994). Furthermore, 20% of the 
cases of Crohn's disease account for 80% of the total cost of the disease, 
generally due to hospitalization, with an average cost of $37,000 per hospitalized 
patient (Feagan et aI., 2000). This highlights the need for efficient, cost effective 
patient care and treatment, in order to keep patients in remission and out of 
hospital. 
Medical interventions in the management of Crohn's disease include 
corticosteroids and immunosuppressives. Corticosteroids, in oral, intravenous or 
topical form, have been the mainstay in the treatment of acute Crohn's disease 
for induction of remission. The main problems with its use are related to its 
signioficant side effects such as moon face, hirsutism, acne, metabolic bone 
disease, osteoporosis, growth retardation etc (Thomsen et aI., 1998). Side 
effects occur regardless of the route of administration, and even though. the 
newer preparation such as budesonide are safer, side effects remain a problem .. 
A significant number of patients have steroid resistant disease, or become 
steroid dependent (Brzezinski, 2000). 
Most patients with Crohn's disease will require one or more surgical procedures 
during their lifetime (Yazdanpanah et aI., 1997). In recent years the surgical 
approach has changed from extensive intestinal resections for cure to limited 
surgery on diseased intestine for improved function (Ralandelli, 1994). Surgery 
is, unfortunately, often associated with recurrence of disease, and is therefore 
not curative. Surgical procedures is generally reserved for the management of 
complications of Crohn's disease, such as obstruction or fistulae formation 
(Latimer, 1978). 
Patients suffering from a chronic illness such as Crohn's disease, often have 
worries and concerns pertaining to their condition. For example, the fear of 











2000). Having an ileostomy may lead to long periods of disability with disruption 
of family, school and business responsibilities, long and frequent hospitalizations, 
malabsorption and malnutrition (Latimer, 1978). Patients requiring ileostomy are 
also exposed to inconvenience related to emptying these bags. There is the risk 
of embarras~merit should the bag break or appliance fail (Murray, 1984). The 
psychological disturbance related to having an ileostomy could therefore have an 
adverse effect on the patient's general well-being. 
At present, no 'specific cure exists for Crohn's disease. Despite reasonably 
effective medical management, relapses and the development of complications 
remain unpredictable, and side effects to treatment common. This uncertainty of 
disease compromises quality of life. 
There is increasing clinical and research evidence that stressful life events, 
traumas, and major losses may have a profound and detrimental impact on 
physical and mental health status (Thompson et aI., 1992; Adler et aI., 1994; 
Creed, 1985; Lowman et aI., 1987). Stress is defined as a psychological 
response composed of negative cognitive and emotional states, elicited when 
demands imposed by events exceed the individual's ability to cope (Cohen and 
Herbert, 1996). However, there is enormous inter-individual variability in the 
response to stress (Sklar, 1979). This variability may be due to differences in 
subconscious or conscious processing of stressful stimuli. Thus an emotional 
traumatic childhood may enhance the subconscious emotional response to 
stressful stimuli, resulting in enhanced physiological responses to stress, 
increased productions of immunosuppressive neuropeptides and hormones. 
There is some ~vidence that psychosocial disruption in utero, postnatally and 
during childhood can have long-term consequences on the immune system (Coe 
et aI., 1987; Ackerman et aI., 1988). 
Psychological disturbances may mediate the development or exacerbation of 











lowers symptom threshold, thereby increasing the number and severity of 
reported symptoms for many medical conditions (Drossman, 1994). These 
factors are frequently not appreciated by the attending physician. 
Similarly, Grohn's disease symptoms combined with existing psychosocial 
difficulties, amplify the symptom experience and lead to health-care seeking, 
refractoriness, and ultimately, referral (Creed, 1985; Berkman, 1985; Lazarus et 
aI., 1984). Continued referral is reinforced because the health care system 
provides only incomplete relief of somatic symptoms, and possible reinforcement 
of pain and suffering through submission to unneeded diagnostic and therapeutic 
procedures (Whitehead et aI., 1982). A "vicious cycle" of psychological 
difficulties, increased symptom severity caused by refractory symptoms, and 
health-care seeking is therefore perpetuated. Refractory symptoms amplify 
psychological disturbances, which in turn worsens symptoms and illness 
behaviour. The cycle continues when the physician does not consider the 
psychosocial determinants of these disorders and responds to the patient's 
distress by administering unneeded testing or treatments (Drossman, 1995). 
It is evident that Crohn's disease is a very complex illness and therefore requires 
a multidimensional approach in its management. Complementary medicine 
could be a useful adjunct to conventional medicine in dealing with a disease of 
this chronic nature. Complementary or mind-body medicine is defined as 
practices that are not in conformity with the standards of the medical community 
and that are not taught as part of the undergraduate curriculum of orthodox 
medicine (Eisenberg et aI., 1993). 
The early custodians of health in most cultures treated both the mind, with 
trances and rituals, and the physical symptoms of the body, with herbs and 
natural remedies. Gradually, treatments for the mind and spirit became 
separated from treatments for the body. This separation gave birth to two 











spawned the subsequent development of reductionism and the biomedical 
approach to ill health, with its emphasis on physical disease, while vitalism was 
more aligned to the principles of Complementary Medical Practice (Watkins, 
1995). However, it has been recognized for some time that mechanistic and 
materialistic ideas are insufficient to explain the human condition and the genesis 
of disease. There have been various attempts to reconcile vitalistic and 
mechanistic approaches to health. The concept of "wellness" evolved out of the 
idea that a healthy mind produced a healthy body and reduced the risk of 
disease. This concept was embraced by some arms of the medical community 
under the guise of holistic or mind-body medicine (Watkins, 1995). 
From the perspective of holistic medicine, mind and body were seen as part of 
the same whole, connected and related in function. Mind-body medicine is 
therefore, seen as a metaphor for an approach to health that focuses not just on 
the physical body and the conscious mind, but also incorporates unconscious 
emotional life, and an individual's spiritual dimension. These forms of 
intervention cover a wide variety of therapeutic practices, from counseling and 
cognitive-behavioural therapy to various complementary medical practices such 
as acupuncture, kinesiology, and massaging which focus on "restoring the 
energy" or electromagnetic flow in the body in an attempt to restore homeostasis 
to a body which has been "unbalanced" through physical or psychological trauma 
(Gallo,2000). 
Although physicians commonly measure the electro-magnetic emissions from the 
body in the form of the electrocardiogram (ECG), electromyogram (EMG), 
electroencephalogram (EEG), it has been difficult to correlate these with the 
"energy field" utilized by practitioners of Complementary Medicine, and research 
in this area has largely been neglected. 
Recently, there has been much interest in the possibility that psychological 











treatments, for the alleviation of chronic pain related to Grohn's disease 
(Maunder & Esplen, 1999; Jantchek et aI., 1998; Schwarz & Blanchard, 1991; 
Shaw & Ehrlich, 1987). Similarly, attempts have been made to determine if 
relaxation therapies such as meditation, hypnosis, and autogenic training can 
alter the human response to disease (Astin, 1997; Hershfield et aI., 1993; Baum, 
1981 ). 
Unfortunately, most of the available studies, utilizing relaxation therapies, suffer 
from design flaws: lack of control groups, lack of follow-up data, biaSing in the 
selection of participants, treatment confounds, and inadequate statistical analysis 
(Wiklund, 1995; Irvine, 1995). What is needed at present are: (1) adjunct 
therapies which take into account the physical, psychological, and biochemical 
aspects of the patient; (2) well-controlled studies, with objective measurement 
before and after treatment, and appropriate statistical analysis of the data; (3) 
follow-up data after the treatment has ended; (4) the use of disease-specific 
health-related quality of life indices to determine the effect of therapy on patient's 
quality of life, and (5) the use of individuals as participants who are drawn from 
the Grohn's disease population, for experimental and control groups - a healthy 
group, or participants from any other disease population, would not be suitable 
as controls due to the chronicity of Grohn's disease. 
The present study was designed to take account of these needs. The modality, 
Kinesiology, which was selected as an adjunct to medical therapy has not yet 
been scientifically researched. However, many claims have been made to its 
efficacy. Therefore, the present study was designed to critically evaluate the 
benefits of this complementary therapy. 
The aim of this study was to determine the role of Kinesiology as adjunctive 











The objectives of this study included the possibility that patients receiving 
Kinesiology in comparison to a group receiving massaging, and a non-treatment 
control group would: 
(1) Red,uce the activity of their disease (measured by lower scores on the 
Crohn's Disease Activity Index), 
(2) Increase their quality of life (measured by higher scores on the Short 
Inflammatory Bowel Disease Questionnaire). 
(3) BenefiCially affect certain psychological characteristics associated with 
Crohn's disease patients (measured by lower scores on the Profile Of 
Mood States). 













2.1.1 Crohn's Disease 
Grohn's disease is a chronic and highly unpredictable nonspecific inflammatory 
disease that affects the gastrointestinal tract. The etiology, diagnosis, treatment, 
and even the definition have challenged physicians since Crohn first described it 
in 1932 (Jewell, Chapman & Mortensen, 1992). The affected areas are 
characterized by a chronic inflammatory reaction, which may be granulomatous, 
necrotizing, ulcerating, and scarring in nature, and which may extend through the 
entire intestinal wall (Baum, 1981). The inflammatory response in the bowel wall 
may lead to ulceration of the mucosa, narrowing of the lumen. These conditions 
may be characterized by intermittent uncomplicated attacks, but often results in 
complications such as obstruction, abscess formation and 'fistulisation (Schachter 
& Kirsner, 1980). Grohn's disease is one of two inflammatory bowel diseases, 
the other being ulcerative colitis. Ulcerative colitis is confined to the large bowel, 
whereas Grohn's disease can occur in any area of the gastrointestinal tract, from 
the mouth to the anus (Rosenberg et aI., 1994; Stenson et aI., 1991). 
The ileum is the part of the bowel most often affected (see Figure 1). Both the 
ileum and the colon could be inflamed simultaneously (ileocolitis) or only the 
colon could be diseased (Crohn's colitis). It is not uncommon to have a normal 
area of the bowel between two areas of inflammation. This is termed "skip 






























2.1.2 Clinical Features 
The disease presents itself with diverse clinical manifestations depending on the 
location, extent, and acuteness of the inflammatory lesion, and its relationship to 
-
contiguous structures. The majority of patients, 45%, will have ileocaecal 
disease, but 30% will have only ileal disease and in 25% the disease is confined 
to the colon (Kirsner & Shorter, 1988). The major systemic manifestations 
include weight loss, fever, nausea and vomiting, anorexia and weakness. Weight 
loss is generally attributed to the patient's anorexia and decreased food intake, 
as well as the catabolic state induced by the active inflammatory process, and 
may be exacerbated in the malnourished patient who is on corticosteroid therapy. 
Fever reflects the underlying inflammatory process, which sometimes indicates 
the presence of an inflammatory mass with localized perforation and multiple 
abscess formation. Nausea and vomiting are common - often as an indication of 
a mechanical intestinal problem such as narrowing of the bowel lumen or as a 
consequence of active intestinal inflammation and swelling (Schachter & Kirsner, 
1980). 
The most common clinical symptoms of Crohn's disease include diarrhea and 
episodes of crampy abdominal pain. The most common clinical signs include 
fever, perianal disease, internal or external fistula formation, and an abdominal 
mass (Kyle, 1972). While some patients experience little or no change in bowel 
habits, most of them have diarrhea of varying severity. This diarrhea is related to 
an alteration in motility in the diffusely inflamed small and/or large intestine 
(Schachter & Kirsner, 1980). Abdominal pain in Crohn's disease is caused by 
transmural inflammation of the bowel including the adjacent mesentery. Spasm 
of the diseased bowel segments and distension of the narrowed inflamed 
intestine may contribute to the discomfort. The often palpable abdominal mass is 
composed of inflamed, thickened intestinal loops, and adherent inflamed 
mesentery, frequently with associated intra-mesenteric abscesses and/or internal 












The incidence and prevalence of Crohn's disease varies in different geographic 
regions. The highest rates are reported in the Scandinavian countries and 
Scotland, folJowed by England and North America (Kildebo et aI., 1990). In the 
Western world the most rapid increase in the frequency of Crohn's disease 
occurred during the period 1965 - 1980 and, after a slower increase, reached a 
plateau in most centers and subsequently decreased in some (Sandler, 1994). 
The incidence of Crohn's disease may be higher in women by as much as 30%. 
The peak age of onset is between the ages of 15 and 25 years. Another smaller 
peak is reported to occur between the ages of 55 and 65 years (Russel et aI., 
1996). 
Tentative epidemiological findings indicate that the disease occurs among all 
races, with a higher incidence among Jews. There is a relatively smaller 
incidence among Blacks (Latimer, 1978). A familial tendency gives patients one 
chance in five of having other cases of inflammatory bowel disease among their 
blood relatives (Mendeloff, 1974). 
Because the disease is chronic, and permits long survival with extensive 
disability, the financial drain on patients and their families can be devastating. 
According to the Report to the Congress of the National Commission on 
Digestive Diseases in 1979, the annual cost of Crahn's Disease and Ulcerative 
colitis was estimated at $645 million, a sum exceeded only by costs for lymphatic 
cancer, cirrhosis of the liver, and gall bladder disease (Baum, 1981). Beyond the 
economic costs ~esulting from expenditures for medical treatment, social welfare, 
and health insurance, there are psychological costs from long periods of 
disability, disruption of family life, education" and business responsibilities. The 
recurrent threat of hospitalization and surgery poses a further problem. This 
highlights the need for efficient, cost effective patient care and treatment in order 












While the etiology of Grohn's disease remains unknown, a variety of 
pathophysiological mechanisms and etiological areas have been explored. 
These include bacterial and viral organisms, disorders of the mesenteric arteries, 
genetic or familial predisposition, immunological deficits, and psychogenesis 
(Glickman & Isselbacher, 1977; Mendeloff, 1974; Baum, 1981). Familial 
predisposition is seen as a possible factor in the etiology of Grohn's disease, and 
therefore, genetic traits could play a role in the pathogenesis of the disease. 
Family and twin studies have shown that between 10 - 20% of patients have 
another first-degree member of the family affected, and 41 % of identical twins 
are affected (Gitnick, 1996). 
There is no evidence that Grohn's disease is contagious. However, some cases 
appear to commence after episodes of gastroenteritis (Smith, 1993). Some 
researchers (Wakefield et aL, 1994) suspect an unusual immunological response 
to an organism which is usually relatively harmless, for example the measles 
virus or mycobacteria (a micro-organism resembling the bacillus causing 
tuberculosis). It is also reported by the same authors that the body's own 
defense mechanism, the immune system, which provides protection against 
infection, is activated in Grohn's disease and may be involved in causing damage 
to the mucosa (the inner lining of the bowel wall). Most drugs used to control 
Grohn's disease do so by suppressing functions in the immune system (Gitnick, 
1996). Although not a proven cause, periods of emotional stress have been 
linked with flare-ups of the disease (Garret et aI., 1990). 
Despite such clinical and pathological investigations, the cause of Grohn's 
disease remains an enigma. Some investigators (Latimer, 1978; Wybrow & 
Ferrel, 1973) have noted that the disease does not have the characteristics of a 
single cause either intrinsic or extrinsic, but is likely to stem from multiple 











seed and soil analogy, where the disease is only experienced when an ecological 
factor (the seed) comes in contact with a predisposed individual (the soil). 
Nevertheless, in order to understand how the disease is perceived from a 
medical perspective, it seems appropriate to view the various models used for 
this purpose . 
• 
2.1.5 The Biomedical Model 
The biomedical model (Figure 2), which is traditional and dominant within 
Western medical education and research, proposes that a biological 
predisposition leads, in a linear fashion, to the development of a medical disease. 
This disease may also be modified by environmental exposure. Furthermore, the 
disease fully explains the illness. Finally, the disease and illness determine the 
clinical outcome, which may also be modified by a psychological overlay, acting 
as a secondary influencing factor (Drossman, 1998). It has been noted by Engel 
(1977) that illness without disease does not fit this model. From a biomedical 
perspective, this illegitimate condition does not exist, and may be labeled as 
"psychosomatic", often this term is used to question the credibility of the 
symptoms, even though they are very real to the patient. 
The term "psychosomatic" refers to the mind-body concept. "Psycho" conveys 
the study of the mind, while "soma' refers to the physical body (Pert, 1997). 
Physicians who adhere to the biomedical model, would have the tendency to 
separate mind and body; to view psychological and social aspects of health and 
illness as unrelated to biological aspects of the disease (Zuckerman, 1989). 
Separation of the psychological from the somatic also permits physicians to 
ignore psychosocial data and interventions and concentrate more on easily 
defined data obtained from laboratory and physical examinations (McKegney, 











satisfactory understanding of the patient's problems and their subjective 





Figure 2: Schematic representation of the Biomedical Model 
(Crossman, 1998). 
2.1.6 The Biopsychosocial Model 
The biopsychosocial model (Figure 3) was proposed by Engel (1977) as an 
alternative understanding of illness and disease. This model proposes that 
illness and disease result from simultaneous interacting systems at the cellular, 
tissue, organismal, interpersonal and environmental levels. It integrates 
biological science with the unique features of the individual, and determines the 
degree to which biological and psychosocial factors interact to explain the 











of Crohn's disease therefore, proposes that early life factors (eg. genetic 
predisposition and environmental exposures) influence later psychosocial and 
physiological functioning, the clinical features of the condition, and, ultimately the 
outcome such as taking medications, physician visits, daily functional status, and 





Figure 3: Schematic representation of the Biopsychosocial Model 
(Crossman, 1998). 
2.1.7 Patient's Disease-related Worries and Concerns 
Complaint-related cognitions and the patient's attribution style are believed to 
influence the course of functional abdominal complaints (Dulmen et aI., 1995). 
Illness-related fears and beliefs about disease, somatic attributions concerning 
gastrointestinal tract and catastrophic cognitions are thought to play an important 
part in the genesis of a physical illness and lead to differences in the way 











influence on how severe a symptom is judged to be, which in turn, might prompt 
the individual to focus anxiously on physical sensations, which may actually 
serve to amplify these initial sensations (Barsky, 1992; Salkovskis, 1989). 
It is reported that patients suffering and simultaneously trying to cope with a 
chronic illness such as Crohn's disease, have many worries and concerns 
related to their condition. As a result, these worries may have a negative impact 
on health related quality of life (Drossman et aI., 1989). Since these patients 
often suffer from specific and socially difficult problems (Moody et aI., 1992), their 
level of psychosocial functioning is also greatly compromised. The highest levels 
of concern relate to: a} the uncertainty of having Crohn's disease, b) the effect of 
treatments such as medication, surgery and eventually having an ileostomy, c) 
developing cancer, d) concerns of a personal or interpersonal nature - low 
energy level, being a burden to others, the ability to achieve one's potential, 
disturbance of sexual/ife, and e) issues related to body-image - diarrhoea, fear 
of faecal incontinence, and flatulence (de Rooy et aL, 2001). Patients with a 
colostomy have an added concern of having an odour or that the bag may 
rupture or leak. This may lead to restrictions in social and professional life 
(Moser et aI., 1995). Mayberry and associates (1992) reported that up to 30% of 
patients with Crotm's disease actively conceal their illness from employers. 
Clinical signs and patient symptoms do not embody the illness experience and 
physicians often underestimate or fail to recognize the functional disabilities 
reported by patients (Calkins et aI., 1991). Therefore, in Crohn's disease as well 
as other chronic ailments, clinical evaluation must also include the patients 











2.1.8 Medical Treatment and Management of Crohn's Disease 
Despite continuous research (Thomsen, et aI., 2002), no specific cure exists for 
Crohn's disease. The broad assortment of approaches which are attempted 
. 
attests to the shortcomings of conventional medical care in treating this chronic 
disorder. Medical therapy has at one time or another included any number of the 
following combinations of medication: 5-aminosalicylate, corticosteroids, 
immunosuppressive drugs, antibiotics and metronidazole. Corticosteroids are 
effective in reducing inflammation during episodes of acute flare-ups (Slonim et 
aI., 2000). Specific immunological therapies such as the use of anti-TNF 
antibiotics have been shown to be effective in the management of Crohn's 
disease. Similarly, drugs including immunosuppressives (azathioprine 6MP) and 
5-aminosalicylate (for colonic disease) have been shown to be useful in reducing 
subsequent relapses (Hueschkel et aI., 2002). Unfortunately, these very same 
medications may also be associated with side effects such as osteoporosis, 
cataracts, glaucoma with possible damage to the optic nerves, bone marrow 
depression and psychic derangements (Sages, 1995). 
Other accepted medical interventions have included surgical procedures, 
Involving resectioning the diseased portion of the bowel, or a bypass which 
excludes the involved area. Even though 70-90% of Crohn's patients eventually 
undergo surgical procedures it is generally avoided and usually reserved for the 
management of complications of Crohn's disease, such as obstruction, 
abscesses, and fistulisation. The reason for such caution is that a greater than 
50% recurrence rate exists five years postoperatively (Casellas et at, 2000). 
Surgical measures are therefore not viewed as curative but seen as a means of 











2.1.9 The Stress-response and Crohn's Disease 
It is generally accepted that stress can produce or aggravate physical symptoms 
although there is no consensus about its role. Human and animal studies have 
shown effects on vascularity, secretion and motility of the gastrointestinal tract 
(Beaumont, 1949). The same author observed changes in gastric activity and 
mucosal appearance in response to psychological and physical stimuli in a 
patient with a traumatic fistula. Others have shown distinct changes in gastric 
function as a response to different emotional states (Almy et al.. 1947). For 
example. fear or depression are associated with mucosal pal/or and diminished 
activity and secretion in the stomach, whereas the opposite is found in such 
emotional states as intense pleasure or anger (Whorwell et al.. 1992). 
Physiological abnormalities have also been shown to occur in other areas of the 
gastrointestinal tract. Jacobson and colleagues (1927) reported that strong 
emotions induced esophageal spasms, and in a more recent study by Young et 
al. (1987) it was shown that when patients with esophageal spasms were 
exposed to complex psychometric tests, high amplitude, high velocity 
esophageal contractions occurred as a response to these stimuli. 
The role of acute chronic life stress has also been studied extensively in 
inflammatory bowel disease. Garret et al. (1991) examined the effect of minor 
daily stressors on the primary indices of Crohn's disease and found a relationship 
between daily stress and self-rated disease severity even after controlling for the 
effects of major life events. Piper and Tennant (1993) reported broadly similar 
results in their patients with chronic peptic ulcer disease. 
According to Thomas Leaman (1992), emotional stress can affect the autonomic 
nervous system of the gut resulting in disruption of the normal peristaltic activity. 











(discontinuous and/or constipation), flatulence and bloating as typified by the 
irritable bowel syndrome. 
The above evidence suggests that psychopathology is intrinsic to inflammatory 
bowel disea;se. How far psychological processes can be implicated in the 
etiology and maintenance of the disease is much less clear. One can only 
assume that psyche and soma are intimately involved and it is important that 
disease of this nature should be approached holistically. 
2.1.10 The Complex links between Stress and Disease from a 
Psychoneuroimmunological perspective 
The word Psychoneuroimmunology (PNf) indicates that the mind (psychology) is 
connected through the brain and nervous system (neurology) to the immune 
system (immunology), thus influencing the body's natural defenses (Hassed, 
1998). PNI therefore, studies the link between stress, psychology, and disease. 
Pavlov in his Nobel Prize talk, first acknowledged the collaboration between 
neural (nervism) and endocrine systems (Winter, 2001). 
There is substantial evidence suggesting that the autonomic, endocrine, and 
immune systems are not autonomous, and that the mind and body communicate 
with each other in a bi-directional flow of neuropeptides, hormones, and 
cytokines (Watkins, 1997; Rossi, 1993). The function of this interactive dialogue 
between autonomic, endocrine, and immune systems, the higher perceptual 
centers and limbic emotional centers is to sustain life and combat disease 
(Watkins, 1997), 
Disease related to stress has been described as "information overload", in which 
the body-mind network is so overloaded with suppressed trauma or unresolved 











for largely autonomic processes such as breathing and blood flow is 
compromised (Pert, 1997; Pert et aI., 1985). Rossi (1993) indicates that it is the 
body's inability to turn off body-mind signals which leads to a chronic excess of 
these arousal messages within the body and consequently an eventual 
compromise. of the body-mind that we call "stress", the "psychosomatic 
response". 
Since it is assumed that Crohn's disease could be a psychosomatic illness 
(Sheffield & Carney, 1976), it could be valuable to look at psychological theories 
of Crohn's disease in order to determine whether there are any reasons for 
suppressed emotions in this population, which could eventually lead to 
somatization of a chronic illness such as Crohn's disease. 
2.1.11 Psychological Theories of Crohn's Disease 
Literature reviews based on the relationship between psychological variables and 
physical symptoms of Crohn's disease (Binder et aI., 1977; Cohen, 1979) focus 
on constellations of personality characteristics associated with the disease; 
family systems and traumatic childhood experiences; and life events involving 
loss and separation. These studies conclude that the most reported personality 
characteristics are dependence, repressed rage, suppression of feelings, 
obsessive-compulsiveness, and anxiety (Miller, 1976; Gerbert, 1980; Cohen, 
1979). Others (McKegney et aI., 1970) theorize that patients with Crohn's 
disease have a constant desire "to be rid of' events in their lives. This 
characteristic can be acted out through the physical symptoms of vomiting and 
diarrhea. 
Clinical and empirical studies, based on family systems and traumatic childhood 
experiences, report that the causal dynamic was the symbiotic tie between 











inward, affecting the digestive system (Paull & Hislop, 1974; Levitan, 1977; 
Engel, 1980; Gerson et aI., 1998). Another study (Jackson & Valom, 1966) 
reported in thirty out of thirty three patients with Crohn's disease who described 
their childhood as traumatic, one or both of the parents were described as 
exhibiting on,e of the following patterns of behaviour during much of the patients 
childhood - offering the patient little affection or closeness, being overly 
domineering or controlling, being physically or verbally abusive, conveying to the 
child a feeling of rejection or being unwanted, or abandoning the patient outright. 
These findings 'were supported by other researchers (Sojit, 1969; Schwartz & 
Schwartz, 1982). 
The theory of loss and separation was developed within the psychoanalytic 
approach (Von Wietersheim et aI., 1992). Authors, Fitzpatrick et al. (1992), point 
out that not only the actual event but also fears of loss and separation can lead to 
the onset of illness. Crohn's disease patients were also described as presenting 
with a rather bleak and negative future perspective which should be interpreted in 
the context of their dependence on others, not only parents but a/so partners 
(KGchenhoff, 1933; Gitnick, 1996; Jantchek et aI., 1998). Two important pOints 
should be noted in assessing these data: (1) since most of the studies reviewed 
were retrospective in nature, one cannot conclude whether or not the psychiatric 
morbidity preceded, antedated, or evolved during the course of illness; and (2) 
such psychological variables are frequently found in patients suffering from a 
variety of chronic physical disorders. 
Recent research has been based on the growing evidence that a history of 
sexual and physical abuse is associated with gastrointestinal illnesses such as 
Crohn's disease (Drossman, 1994; Felitti, 1991; springs, 1992; Fry, 1993). 
Psychologists and psychiatrists now recognize several psychiatric syndromes 
(for example, somatization disorder, severe depression, post-traumatic stress 
disorder, anxiety and personality disorder) as consequences of abuse (Stein, 











the physical concomitants of sexual and physical abuse, that is, their association 
with certain medical disorders and their effect on health care (Felitti, 1991; Briere, 
1992; Springs et aI., 1993; Laws, 1993). 
It was founc;l that patients with functional Crahn's disease who are seen in 
medical centers have a high frequency of psychiatric comorbid conditions 
(Walker et aI., 1992; Lydiard et aI., 1993) and are likely to communicate 
psychological distress through physical symptoms. Furthermore, they may not 
acknowledge a' relation between psychological difficulties and their symptoms 
(Drassman et aI., 1988; Toner et aI., 1992), which reinforce their belief that they 
have a serious medical disorder. 
2.1.12 Abdominal Symptoms and the Mind 
Gut reactions have been reported to be spontaneous feelings not filtered by a 
sophisticated cerebral cortex (Watkins, 1997). Most people are quite 
accustomed to the sensation of "butterflies" or urgency and bowel frequency 
when faced with a stressful event. These and other abdominal symptoms, 
particularly those due to changes in intestinal motility, are thought to be mediated 
by the autonomic nervous system, indicating a clear connection between brain 
and the gut (Creed, 1992). 
History indicates that beliefs about changes in mood were also focused on the 
abdomen. Melancholia, that is "black bile", believed to be the predecessor of 
depression, was thought to emanate fram an abnormality of alimentary functions 
(Thompson, 1993). Many early remedies for mood disorder is reported to have 
focused on the alimentary tract which seemed to be an approachable target for 
the herbal remedies of early medicine (Creed, 1992). The importance of 
abdominal symptoms that are not related to any defined organic disease is no 











extremely common. They have even affected and sometimes dominated the 
lives of many highly successful individuals. Charles Darwin was racked with 
abdominal pain which, in later life, restricted his movements away from home, as 
did the abdominal symptoms of Thomas Carlisle. Sigmund Freud clearly 
recognized the importance of the gastrointestinal tract as a mirror of the mind 
and our emotions, and based some aspects of his analytical theories of 
personality development on the beginning and end of the gastrointestinal tract, 
namely the mouth and the anus (Watkins, 1997). Since it appears that there is 
some link between mind and gut, it seems appropriate that treatment in the 
maintenance of gastrointestinal disorders should involve psychological 
intervention with a focus on teaching patients more effective coping mechanisms. 
2.1.13 Psychological Intervention with Gastrointestinal 
Disorders 
A number of uncontrolled and semi-controlled studies using psychological 
treatment approaches have been carried out with gastrointestinal disease 
patients (Svedlund et aI., 1983; Blanchard et al. , 1988; Latimer, 1978). Much of 
the earlier work was based on patients who were seen after several previous 
medical referrals, ineffective attempts at treatment, and a variety of potentially 
conflicting explanations of the problem. There is now a greater emphasis on 
liaison work, with those involved in psychological treatment working in primary 
and secondary medical settings. The four main types of psychological 
treatments that have been used include psychotherapy, hypnotherapy, behaviour 












It is interesting that even though a relationship between psychological variables 
and the disease was recognized by Crohn himself (Crohn, 1949), few 
investigators. have examined this relationship, and still fewer have attempted to 
influence these factors through experimentation. Paulley's work (1971) is one of 
the rare reported studies acknowledging the above association, and one which 
attempts to influence it through psychotherapeutic intervention. Paulley utilized 
long-term psychotherapy together with conventional medical care 
(Corticosteroids and antibiotics) in the treatment of 40 Crohn's patients. From 
the patient's responses (39) to questionnaires, he determined that psychotherapy 
was a decisive influence in the recovery of 30 respondents. Unfortunately, 
Paulley's methodology is vulnerable to criticism since he does not provide an 
adequate control condition, nor does he elaborate on how or who determined 
that psychotherapy was a decisive factor in recovery. 
Another example of using psychotherapeutic intervention with Crohn's disease is 
offered by Sperling (1960). In her single case study, the technique of 
psychoanalysis was employed to successfully treat a 44-year old male with a 
greater than 20 year history of illness. 
The conclusions of both Paulley's and Sperling's studies can be faulted on a 
variety of methodological issues. At the same time, they have also neglected 
practical problems of costs and feasibility in their choice of intervention 
strategies. Specifically, individual psychotherapy and psychoanalysis are but a 
further burden fqr the Crohn's patient since these treatments are costly in both 
time and money. Paulley was seeing some patients for up to 18 years, and 
Sperling's work lasted 3 years (8aum, 1981). Furthermore, Paulley's approach 
and Sperling's psychoanalytic method quite realistically might have precipitated 
and/or magnified existing attitudes of dependency, thereby contributing to the 












This technique deals directly with the problem at hand, and involves what is 
termed gut-centered hypnosis, which enables the patient to exert some control 
over the activity of their gastrointestinal tract. In a study by Whorwell et al. 
(1984), the therapeutic effects of hypnotherapy were assessed and compared 
with the use of supportive psychotherapy in 30 patients with refractory Irritable 
Bowel Syndrome (IBS). In the group receiving hypnotherapy, seven 3D-minute 
sessions of gut-centered hypnosis were administered to each patient. In addition 
the patients were given an auto-hypnosis tape to be used at home on a daily 
basis. 
At the end of the three-month study period, the hypnotherapy group reported a 
significant reduction in their IBS symptoms. In addition, an overall improvement 
in their general well-being was also reported. These findings differed significantly 
from both the psychotherapy and control group. There were however, small but 
significant improvements reported by the psychotherapy group and these were 
confined to abdominal pain, abdominal distension, and general well-being. At 
follow-up, the hypnotherapy group reported no incidences of relapses or no other 
new symptoms (Whorwell et aI., 1984). Whorwell's group has extended its work 
on the use of hypnosis in gastrointestinal disorders and found that these patients 
also responded favourably to gut-centered hypnosis (Whorwell, 1991). 
2.1.13.3 Behavioural Therapies 
The application of behavioural therapy involves teaching the patients various 
exercises and strategies to aid symptom control. Progressive muscle relaxation 
therapy and thermal biofeedback have been used to treat patients with 











this patient group a clinically significant reduction in their gastrointestinal 
symptoms was achieved (Milne et aI., 1986; Corney et aI., 1991). 
2.1.13.4 Cognitive-behavioural Strategies 
One of the most effective psychological treatments now being offered to patients 
is a combination of relaxation techniques and cognitive-behavioural strategies 
(Skinner et aI., 1990). This multidimensional approach is aimed at changing the 
way in which patients evaluate the meaning of their abdominal symptoms. It is 
also aimed at changing maladaptive behaviours that the patient has developed 
as a response to coping with their illness. For example, changes in toilet use, 
avoidance behaviour and excessive use of medication to help control bowel 
functioning (Watkins, 1997) 
From the above evidence supporting the effectiveness of psychological 
intervention in the management of gastrointestinal disease, it is reasonable to 
explore further the beneficial effects of other forms of psychotherapeutic 
intervention, which may prove more practical and efficient in the treatment of 
Crohn's disease. With these considerations in mind, the psychotherapeutic 
procedures of Kinesiology and Massaging was proposed as the treatment of 












Kinesiology, while practiced by a large number of therapists over the last 30 
years, has to date accumulated mostly anecdotal clinical data and has not been 
subjected to critical clinical investigation in the experimental setting. Except for a 
few Kinesiology text books and workshop manuals, no research articles on 
Kinesiology were available. Therefore, other fields of literature, dealing with 
stress release therapies (e.g. meditation, psychotherapy, and autogenic training) 
in the treatment of Crohn's disease, were also reviewed. 
Kinesiology is a psychophysiologic form of psychotherapy designed to self-
generate a state of psychological and physical relaxation, thereby, restoring the 
body's homeostasis - a state completely opposite to that elicited by stress. 
Through the generation of this balanced state, it is believed that the recuperative 
and self-healing processes of the body are facilitated, "the emphasis is not on 
trying to control the natural system, but rather on helping natural systems use 
their inherent potential of self-regulatory adjustment more fully" ( Luthe, 1979, p. 
167). 
The concept of "self-healing" was well appreciated by the ancient Greeks. 
Hippocrates observed in his treatis Of the Epidemics, that, in most diseases, 
there was a natural tendency to cure (Margotta, 1996). 
2.2.1 Psychological Science and Kinesiology 
With regard to psychological functioning and dysfunction, there are a variety of 
theoretical models or frameworks that attempt to explain and make predictions, 
with psychotherapies and other kinds of interventions resting upon them. For 
instance, we can think of psychological disturbance as a manifestation of 











conditioning, systemic interaction, maladies of brain structures and 
neurochemistry, heredity, and so on. We assume that all of these facets and 
conceptualizations are relevant and valid to a greater or lesser extent, depending 
on the condition under consideration. Therefore, if we were to consider 
depression ~s if it were solely a chemical imbalance, without attending to the 
psychological and physical aspects of the condition, we would be limited in our 
ability to assist the patient in achieving ongoing relief. Many reductionistic 
models reach their limits of applicability quickly (Gallo, 2000). It is therefore 
necessary to search for a broad field theory of mind that will allow one to 
determine precisely which aspects of functioning are most relevant. 
The technique of Kinesiology is based on the "Triangle of Health" principle 
(Figure 4). This paradigm presents humans as existing in physical, psychological, 
and biochemical dimensions (Thie, 1996). Therefore, from a Kinesiologic 
perspective, it is believed that any stressful event would negatively influence 
biochemistry. This in turn may cause further imbalance in the psychological 
state, which could then impact negatively on the physical structure creating signs 
and symptoms of disease (Deal, 1998). 
Biochemical 
(Physiologi9a1) 












2.2.2 The Origin of Kinesiology 
The word "Kinesiology" is derived from the Greek and generally translates as 
"study of motion". In this case it refers to the study of the mechanics of bodily 
motion, especially muscle movements and their relationship to the rest of the 
complex body system. The science of manual muscle testing was first 
developed in the early 20th century by a Boston orthopaedic surgeon, R.W. 
Lovett. He applied muscle testing to trace spinal nerve damage because it was 
found that muscles testing "weak" often had a common spinal nerve (Krebs, 
1998). 
Dr George Goodheart, a Detroit based Chiropractor, began to implement the use 
of muscle monitoring in his practice. He found some patients had specific 
muscles that would test weak when they had certain types of diseases. For 
instance, he noted the pectoralis major clavicular muscle (PMC) would generally 
test weak in patients who complained of stomach ulcers. He would apply a 
certain chiropractic manipulation, called origin and insertion (stimulating the 
muscle joint and bone that serves as a lever for muscle contraction), for the 
treatment of ulcers and reassess the strength of the PMC muscles. After these 
treatments the muscles showed strength indicating that the ulcers have 
improved. This finding seemed to provide evidence of a relationship between 
ulcers and the muscle response, and the efficacy of the chiropractic treatment 
(Goodheart, 1986). 
In his quest for answers, Goodheart showed interest in the work of an early 
American osteopath, Frank Chapman, who had observed that many types of 
pathologies, or the symptoms of diseases, had their origin in sluggish lymph flow. 
which means that over time, tissues become more toxic and less functional 
(Guyton, 1991). Chapman theorized that there were many points on the bodies 
of individuals indicating various symptoms of disease, which, when palpated or 











become less tender and this was associated with improvement in the disease 
condition. He called these Chapman Reflex Points (Walther, 1981). Goodheart 
suggested that many of the disease conditions described by Chapman as being 
associated with a specific Chapman Reflex Point could also be associated with a 
specific mus~le weakness. He then found that rubbing the reflex point which 
Chapman had assigned to a disease would often strengthen the muscle 
associated with the same pathology (Krebs, 1998). 
In the 1930's another American Chiropractor, Terence Bennett, presented his 
model of restoring health based on proper blood flow. Like the lymph system, 
when blood flow becomes congested, tissues do not get the right amount of 
oxygen and nutrition. He reasoned that this set up the prime condition for 
diseases to manifest. Like Chapman, Bennett had worked out his own set of 
reflex points. Most were on the head and upper body with a few below the waist 
and on the legs. Bennett theorized that the application of light pressure to these 
points would stimulate increased blood flow to the associated tissues and 
organs. As with Chapman's work, it was shown that stimulation of these Bennett 
Reflex Points would often result in major improvement in the condition being 
treated (Bennett, 1977). 
By synthesizing these theories, Goodheart pioneered a system that combined 
work done by his predecessors: Chapman's· Points (for lymphatic function), 
Bennett's Points (for vascular function), the origin/insertion technique (for muscle 
problems), and muscle testing/monitoring for feedback in both diagnosis and 
therapeutic efficacy (Gallo & Vincenzi, 2000). 
Dr Goodheart, who had made the seminal breakthrough that remains the core of 
Kinesiology therapy, made a further contribution. He believed that when muscles 
did not respond either to originlinsertion stimulation, Chapman's or Bennett's 
Reflex Points, that running his. hand just above a specific meridian (energy) 











muscles would strengthen. Again it was assumed that a relationship between a 
specific muscle response and a specific meridian existed (Goodheart, 1966). 
The Chinese system had provided a layout of thousands of years of observations 
about the energetic system and the principles by which it works. To this body of 
knowledge, Goodheart added the muscle response correlation, which meant the 
energy balance of these meridians and associated organs could be readily and 
consistently ascertained by direct muscle feedback (Krebs, 1998). 
2.3 KINESIOLOGY CONCEPTS AND ASSUMPTIONS 
2.3.1 The Body's Bio-energy System 
The philosophical basis of Kinesiology is that health is wholeness and balance of 
subtle bio-energy and that ill health relates to an imbalance of this energy 
(Seaward, 1994). 
Subtle energies have been long recognised within Eastern traditions and are 
known by different names, for example, Ch'i or Prana. Ch'i is based on the 
Eastern philosophy that there is an energy that flows within us in a harmonious, 
balanced way, an active balance that is known as health. It is believed that when 
this energy is not flowing as it should, there is disharmony and imbalance, which 
is known as illness (Dawson, 1999). Teeguarden (1987) defines Ch'i or Prana as 
a life force of subtle bio-energy which influences balance both in the body and in 
the psyche and can regulate physical and psychological functioning. 
With these cautions in mind, it has been proposed by Gallo (2000) that 
psychological functioning in g~neral and psychological disturbances in particular 
can be effectively viewed, to a significant degree, in terms of subtle bio-energy 











health in general, is assumed to be consistent with a balance or unobstructed 
current of bio-energy, while psychological disturbances are consistent with 
imbalance or encumbered "flow". 
The use of Fmergy to heal human illness has been known throughout history 
(Gerber, 1988). Chinese acupuncture heals, based on restoring the flow of Ch'i. 
Healing in the deepest sense is difficult to perceive. Modern medicine is not 
certain what it is that enables healing to occur. Five thousand hears of Chinese 
health care and 'philosophy, 3,000 years of Indian Ayurvedic and the more recent 
Western Homeopathic philosophy all reason that there is an innate intelligence in 
the body which is always moving toward dynamic balance and therefore weI/ness 
(Chopra, 1989; Passwater, 1994; Capra, 1982). 
2.3.2 Meridians 
The meridian system (energy pathways) is believed to communicate energetic 
information throughout the human body (Ga/lo & Vincenzi, 2000). The theory of 
the human energy system eventually led to the development of acupuncture. 
This is a procedure by which the body's energy is assumed to be altered by 
stimulating, with needles, specific points (acupressure points) along twelve major 
energy pathways that are known as meridians (Gerber, 1996). 
According to Chinese medicine, there are 14 major meridians in the body. Two 
of these meridians, the Governing and Central meridians, is believed to flow up 
from the region of the crotch. The Central meridian runs up the midline in front of 
the body to a point just below the bottom lip. The Governing meridian runs from 
the coccyx, up the spine, over the top of the'skull to a point just below the nose 
on the upper lip. The other 12 meridians are bilateral (Xinnong, 1987). Each of 
the meridians is believed to flow through a specific organ in the body for which 











intestine, large intestine or bladder (Figure 5). The entire system is assumed to 
be interconnected so that the life energy travels from one meridian to the next, 
circulating throughout the body (Gerber, 1996). 
It is believed. that each one of these meridians consists of acupressure points. In 
acupuncture treatments, these points are used. It has been assumed that 
acupressure points perform various functions. Therefore, during acupuncture 
therapy, needles are inserted into the body at selected tonification or stimulation 
points (to increase the flow of energy), or at selected sedation points (to 
decrease the flow of energy). Through trial and error, acupuncture has been 
developed and used by Chinese physicians to eliminate pain and to treat a wide 
variety of illnesses. Several countries now use acupuncture as an alternative 
anesthesia during surgery (Gallo & Vincenzi, 2000). 
Although acupuncture has been developed and used by Chinese physicians, 
increasingly, people are accepting acupuncture as a viable alternative health 
care treatment (Gallo & Vincenzi, 2000). The World Health Organisation cited 
104 conditions that can be treated by acupuncture, including gastrointestinal 
disorders (Burton Goldberg Group, 1993). 
From a scientific viewpoint, trying to prove that there is an energy system with 
acupressure points is very difficult. There have been several attempts to 
document the existence of this energy system. Langman (1972) examined the 
relationship between energy and disease. He found that in a sample of 123 
women with malignant cervical conditions, 5 had a positive energy charge in the 
cervix and 118 tlad a negative energy charge. The numbers were reversed in 
the control sample that had no cancerous conditions. This study does not prove 
tl1at negative polarity causes cancer, because it is possible that cancer itself 
leads to the negative charge. However, this research does suggest that a 
specific energy difference exists between those who are healthy and those with 











Figure 5: The 14 major meridians providing the flow of energy throughout 











2.3.3 Acupressure Points 
There have been several attempts to document the existence of acupressure 
points. Robert Secker (1990), an orthopedic surgeon, examined the theory that 
meridian acupressure points are electrical conductors and that meridians are 
used to send messages back and forth from the brain and the injury site - to 
promote healing and create the conscious perception of pain. He developed an 
interesting and pertinent research approach. He proposed that the meridians 
were the electrical conductors that relay information from the site of an injury to 
the central nervous system. He thought that perhaps acupuncture needles 
served to block the pain message from getting to the brain by short-circuiting the 
electromagnetic current in the meridian (Secker & Seldon, 1985). 
Another researcher, Maria Reichmanis (1976), a biophysicist, and her associates 
developed a device that could be rolled along the assumed meridians to detect 
differences in electrical skin resistance. They theorized that if an electrical 
charge truly existed at the location of the acupressure point, there would be a 
difference in skin resistance at that point as compared to the surrounding skin. 
Their findings were consistent enough across subjects to strongly suggest that 
meridians and acupressure or acupoints exist (Reichman is, Andrew & Secker, 
1976). 
It is further suggested that many of these acupressure points, depending upon 
their location on the meridians, have distinct functions, accounting for unique 
vibrations or energy frequencies as well as neurologic specificity (Gallo, 2000). It 
is believed that at some locations there is a very subtle difference (Yang, 1989). 
This is consistent with the literature on acupuncture, which describes a rich 
variety of individual points. For example, "alarm points", which are employed in a 
number of systems, are utilized for diagnosis and treatment. "Sedation points", 
are believed to balance overactive meridians, while "tonification points" are 











model presented above, it is believed that meridians are not only associated with 
specific organs and muscles (Goodheart, 1987; Thie, 1973), but also with 
specific emotions (Diamond, 1985). 
2.3.4 Meridians and Emotions 
It is believed that there is an interface between meridians and emotions, such 
that various positive emotions are evident when the meridians are balanced (Le. 
love, joy, cheerful, forgiveness, tranquility) and various negative emotions 
predominate when the meridians are disrupted (Le. hate, sadness, unhappiness, 
anger, disgust). It has been reported by some authors (Becker & Selden, 1985) 
that an association between specific meridians and certain emotions exist. 
Although there is one continuous, interconnected bio-energy system, the system 
is nonetheless divided into segments or meridians, and within each . of the 
meridians are acupressure points (Becker & Selden, 1985). Diamond (1997) 
asserts that he arrived at his designations by way of manual muscle monitoring. 
2.3.5 The Concept of Muscle Monitoring 
The term "indicator muscle" was introduced to describe a muscle which showed 
a transient loss of isometric muscle strength in relation to a stimulus (Walther, 
1988). Research to test the validity of this new evaluation tool was initially 
conducted by chiropractors in clinical practice (Walther, 1988; Goodheart, 1985), 
however, these findings were never published. 
Rolfes (1996) evaluated the nature and phenomenon of muscle monitoring which 











relationship between individual muscles and spleen meridian. In a double-blind 
study, she tested the hypothesis that indicator muscle response would be 
changed when the magnetic energy in the spleen meridian was altered. Two 
examiners tested three groups of healthy participants. The first group consisted 
of 29 stud~ntsand Examiner A performed 290 tests. The second group 
consisted of 30 different students and Examiner A performed 300 tests. The 
third group consisted of 24 students and a different examiner, Examiner B who 
performed 240 tests. Rolfes (1996) found that IMG was a reliable tool to 
evaluate change of magnetic polarity over specific acupressure points. 
In the second part of her study, Rolfes (1996) considered whether stressful 
stimuli and negative emotional attitudes could elicit IMG. The results of her 
experiments revealed that IMG or "Kinesiological muscle testing" monitors a 
subtle loss in neuromuscular integrity due to stressful stimuli. 
The above study investigated whether negative emotional attitudes would give a 
changed indicator muscle response, hence the term - indicator muscle change. 
It is thus clear that muscle monitoring is simply that, monitoring a change, which 
obviously entails issues of reliability and validity. The test is employed as an 
indicator. In this regard, if a muscle test were to indicate that treating a specific 
meridian was needed to alleviate a disturbance in the energy system of the body, 
the test would not be accepted as the final authority. The outcome would be 
noted. If the outcome was positive, one would be inclined to conclude that the 
test was accurate, that it correlated well with treatment needs. If, on the other 
hand, the problem is not alleviated, one could question the validity of the test in 
that particular context. While some other factor might be involved, one would 











2.3.6 The Muscle - Emotion Interface 
It was theorized that the subconscious area of the brain, that controls or elicits 
our emotions, is located in the limbic brain (Noback, 1991). There are direct 
neurological'connections between the limbic brain and the pathways that control 
the muscle tone and tension (Strorninger & Demarst, 1991). Tightness in the 
neck when we are anxious and worried; churning stomach when we are nervous, 
are examples of mental events that have a telling physical effect on our bodies. 
This is thought to occur because the part of the brain that controls our emotional 
and physical survival programs also subconsciously sets the tone of our 
muscular system (Gallo, 1998). Therefore, it is assumed that our emotional 
states are very graphicaHy portrayed in our physical postures - a depressed or 
unhappy person would present with a posture of slumped shoulders, dropped 
head, drooping mouth or downcast eyes. 
Since Kinesiology monitors muscle tone, it is linked to the emotions that are 
setting that tone. When monitoring a muscle, it is assumed possible to get in 
touch with the interface between the neurological physical body, and the 
emotions and thoughts that affect that body (Krebs,1988). Emotions and 
thoughts may affect muscle function through two pathways (Figure 6). One is 
through the Limbic brain and its effects on muscle tone. The other is via the 












Figure 6: The Emotional - Muscle Interface (Krebs, 1998). 
2.3.7 Emotional Stress Oefusion (ESO) 
Stokes and Whiteside (1985), while working with severely depressed patients, 
discovered that unresolved emotional stress was the basis of most blockages in 
the bodily system which hampered personal, emotional and spiritual growth, as 
well as the body's own self-healing mechanism. They developed an emotional 
defusion technique which was not just the release of emotions, but it served to 
diffuse and then reintegrate into the system what had otherwise been unresolved 
emotional experiences (Krebs, 1998). 
ESD is a technique that is believed to alter the blood flow patterns in the 
brain - under stress the brain redirects blood flow, which contains vital oxygen 
and glucose, to those areas of the brain that are most important for survival. 











centers become extremely active and access the cortical areas at the back of the 
brain where past memories have been stored. These areas therefore, demand 
high levels of blood flow. This flow of blood to areas in the frontal brain, that are 
involved with associational thinking, our conscious thoughts, is temporarily shut 
down so that our thoughts do not interfere with the ability to react. Threatening 
circumstances require one to react and not think about action. This immediate 
action is really a re-action or a re-enactment of a survival program that has been 
successful in the past. In other words, when the brain becomes aware of threat, 
within 1/S00th of a second the limbic brain reviews all of the experiences you 
have had that closely resembles the one you are presently undergoing. Without 
your conscious awareness, the limbic brain chooses the past program that had 
the highest survival rate in similar situations. This program is then relayed and 
directs your behaviour, serving as a reference, so you can re-enact the behaviour 
that enabled you to survive in the past (Krebs, 1998). 
Information regarding the origin of the specific emotional issue is obtained by 
implementing the technique of muscle monitoring. 
2.4. KINESIOLOGY THERAPY 
Kinesiology therapy is based on six main procedures - (1) Assessing for 
neurologic disorganization; (2) a 14 muscle assessment utilizing the process of 
muscle monitoring; (3) a neurolymphatic stimulation (using Chapman's Reflex 
POints) to stimulate the lymph flow; (4) a spinal reflex stimulation to enhance the 
flow of cerebrospinal fluid; (S) a neurovascular stimulation (using Bennett's 
Reflex Points) to increase energy flow from the brain to all parts of the body; and 
(6) Emotional Stress Defusion (ESD) to desensitize all emotiona1 and 











2.4.1 Neurologic Disorganization 
The phenomenon of neurologic disorganization, also referred to as polarity 
switching, is a significant block to energy diagnostic and treatment effectiveness. 
When using 'manual muscle testing as an indicator for therapeutic approach, it is 
assumed necessary that the nervous system be organized to provide correct 
information, otherwise, the therapy might be directed to the wrong area of the 
body (Walther, 1988). 
The functioning of muscles in healthy neurologically organized people shows 
consistently predictable characteristics. Most muscles are paired, so that one 
side tenses or facilitates when the opposite side relaxes or inhibits. This 
coordinated action of muscles is mediated by the spinal cord and the central 
nervous system through an intricate interplay of afferent (conduct impulses from 
the periphery of the body to the brain or spinal cord) and the efferent (conduct 
impulses from the central nervous system or spinal cord to effectors, either 
muscles or glands that are capable of responding to the nerve impulse) signals. 
The various sensory receptors send signals to the central nervous system, which 
in turn regulates facilitation and inhibition of the respective muscles in a 
coordinated, organized fashion. When conflicting afferent signals are sent to the 
central nervous system the person becomes neurologically disorganized (Gallo, 
2000). 
Disorganized muscle functioning appears to entail disorganization of the cerebral 
hemispheres, as well as bodily polarity imbalances. For example, disorganization 
between the hemispheres and the body's bilateral symmetry is consistent with 
right sidelleft side polarity imbalance and anterior/posterior (Le. fronUback) and 











2.4.2 Fourteen - Muscle Assessment 
Muscle monitoring is used as a biofeedback mechanism that allows for the 
assessment if the body's functioning level, and to assess for compromised areas 
so that correction procedures may be performed which will allow the body to 
perform its nFltural functions of self-healing, regenerating and repairing. Muscle 
monitoring consists of assessing each one of the 14 muscles (Figure 7) that are 
related to the 14 major meridians in the body (Table 1). An unlocked muscle 
response will indicate a restriction in the energy flow of the related meridian 
which will have 'to be corrected by means of a Neurolymphatic massage, Spinal 
reflex stimulation, Neurovascular stimulation or an Emotional Stress Defusion 
(Gralton & Gralton, 1999), 
Table 1: 14 Muscles used for Muscle monitoring and their corresponding 
meridians. 
MUSCLE CORRESPONDING MERIDIAN 
Supraspinatus Central 
Teres Major Governing 
Pectoralis Major Clavicular Stomach 
Latissimus Dorsi Spleen 
Subscapularis Heart 
Quadriceps Small Intestine 
Peroneus Bladder 
Psoas Kidney 
Gluteus Medius Circulation Sex 
Teres Minor . Triple Warmer 
Anterior Deltoid Gall Bladder 
Pectoralis Major Sternal Liver 
Anterior Serratus Lung 















Figure 7: 14 Muscles used for assessment (Thie, 1998). 
2.4.3 Neurolymphatic Massage 
Latissirnus Dorsi 
\.:lIUI,I:tUl:> Medius 
The lymphatic system is part of the overall circulatory system. The lymph acts as 
a drainage system. It also produces antibodies, and transports a quarter of the 
white blood cells which are responsible for fighting infection (Gerber, 1996). 
Neurolymphatic reflex points are located mainly on the chest and back of the 
body (Figure 8). Their location does not necessarily correspond to the lymph 
glands, but are related energetically. Stimulation of the neurolymphatic reflexes is 
believed to aid in lymph flow. Therefore, when a muscle does not lock, 











the specific organ and will reinstate the integrity of the muscle. The previously 
unlocked muscle should now lock when tested (Gralton & Gralton, 1999). 
'Peroneus 
:.:.::~t===:(GThlurcus Mcdi;:·us=-,· __ ::::::tt~ 
1------PUdaua------~~ 
Figure 8: Neurolymphatic or Chapman Reflex points situated on the front 











2.4.4 Spinal Reflex' Stimulation 
When the muscle weakness is bilateral (both sides unlocking), the spinal reflex 
points should be stimulated first. Unlike neurolymphatics, these rubbing points 
are located dh the spine itself (Table 2). The spinal reflex point is rubbed up and 
down the vertebrae, covering one or two levels above and below the involved 
correction point. If, after having attempted the neurolymphatic massage as well 
as the spinal reflex stimulation, the muscle still tests weak, the neurovascular 
holding point will be the next option (Gralton & Gralton, 1999). 
Table 2: Spinal reflex points situated on the spine and the corresponding 
muscles (Gralton & Gralton, 1999). 
MUSCLE SRP 
Supraspinatus C1-2 
Teres Major T2 
Pectoralis Major Clavicular T5 





Gluteus Medius L5 
Teres Minor T2 
Anterior Deltoid T4 
Pectoralis Major Sternal T5 
" 
Anterior Serratus T3-4 











2.4.5 Neurovascular Holding Points 
The neurovascular holding points are located mainly on the head (Figure 9). By 
holding the appropriate point the neuronal associations and acupuncture 
meridians ar,e stimulated. This in turn promotes increased blood flow to the 
muscle and the related organ or gland. The previously unlocked muscle should 
now lock when tested (Gralton & Gralton, 1999). At the end of this session the 
body will be assessed for emotional blockages using muscle monitoring to 
determine the specific years when traumas or emotional disturbances occurred. 
If, however, there is an indication that emotional or psychological issues are 
present, the second session will consist of the ESD procedure to desensitize all 
these issues (Thie, 1998). 
4 Supraspinatus. 1 Psoas 
Subscapularis 8 Teres Major 
Anterior Deltoid Teres Minor 












11 Supraspinatus 10 Quadriceps 
Pectoralis Major Clavicular Gluteus Medius 
Peroneus Fascia Lata 
12 Pectoralis Major Sternal 
15 Teres Minor 
Figure 9: Neurovascular holding points or Bennett Reflex points situated 
on the head and their corresponding muscles (Thie, 1998). 
2.4.6 Emotional Stress Defusion 
The Emotional Stress Defusion is a very important aspect of Kinesiology 
therapy .. During this session, deep rooted emotional stress, related to past 
traumas, accidents, emotional overload, pressure from work or relationships etc. 
are released and desensitized. Patients are taught the necessary skills to deal 
with future issues in a positive way. Since a number of researchers indicate that 
Crohn's patients have unresolved issues (Jackson & Yalom, 1966; Sojit, 1969; 
Schwartz & Schwartz, 1982), the emotional stress therapy would be most 
appropriate for this population. 
2.4.7 Kinesiology Therapy and Crohn's Disease 
While there are no published reports of utilizing Kinesiology therapy with Crohn's 
disease patients, there are numerous experimental findings demonstrating the 
beneficial effect of relaxation and stress release therapies upon patients with a 
similar inflammatory bowel disease, Ulcerative colitis (Schwartz & Blanchard, 











Baum, 1981). According to these researchers, relaxation therapies (Meditation, 
Autogenic training, Psychotherapy, Hypnosis etc.) may psychophysiologically 
facilitate normal intestinal functioning by relieving stress and normalizing 
autonomic regulation - contributory, and possible causative factors in 
exacerbations of Crohn's disease symptomatology. However, all of these studies 
• 
used very small samples, and none employed adequate comparative control 
groups. With this cautionary note, a review of this pertinent literature follows. 
The largest sample utilizing a relaxation therapy, Autogenic training, with a 
nonspecific, ulcerative disease of the colon is Schaeffer's (1966) study. He 
investigated 32 Ulcerative colitis patients, of which 9 cases were judged clinically 
mild, 10 were moderate, and 13 were severe. In 23 cases "rest-hypnosis" and 
Autogenic training was occasionally added to medical care. Medication was 
used sparsely, and in some cases not at all. Results indicated that only 3 
patients showed no improvement, the remainder improved significantly, and 23 
went into complete remission (Schaeffer, 1966). These results were drawn after 
treatment periods ranging from 12 months to 12 years. Schaeffer concluded 
from his work the following: 
Autogenic training (a) stabilizes and normalizes disturbances of relevant 
autonomic functions better than any other method; (b) reduces progressively the 
frequency of relapses; (c) shortens and diminishes the degree of severity of 
relapses; and (d) eliminates the necessity of medication in most cases or 
reduces required medication in others (in Luthe, 1969, p. 24). 
Another study (Shaw, 1987) cites the use of relaxation therapy with 20 inpatients. 
Each patient received 6 weekly training sessions in the technique of progressive 
relaxation. Another 20 patients with the same condition constituted the control 
group. There were no significant differences between experimental and control 
subjects before treatment but immediately after treatment and also at the 6-week 











measures. The experimental group showed a remarkable improvement. Some 
examples of the changes reported were: weight gain, improved mood, reduced 
stress level, less pain, increased appetite and normal stool. 
Additional supportive evidence for the use of relaxation and stress release 
therapies with Grohn's disease is taken from its demonstrated ability to improve 
psychological symptoms commonly found among these patients - anxiety and 
depression (Porcelli et aI., 1994; Richards et aI., 1994; North et aI., 1994; 
Schwartz et aI., 1982). 
In sum, since Kinesiology therapy is a process of restoring balance to a body that 
has been debilitated physiologically as well as psychologically, it appears an 
appropriate choice of treatment for Grohn's disease for the following reasons: (1) 
there is evidence to suggest that relaxation and stress release therapies are 
useful in diminishing Grohn's disease symptoms; (2) it would be helpful in 
treating anxiety, depression, and other emotional conditions; (3) the degree of 
dependence on the attending physician is minimal since patients learn to do 
some of the therapeutic work by themselves at home; (4) the combination of 
correction techniques available allows the therapist to tailor an effective flexible 
treatment program to the patients and the particular disorder; (6) it has the 
potential of providing a cost-effective therapeutic procedure; and most 
importantly (7) these are all effects which could be valuable in adaptation to 














One hundred and fifty Crohn's disease patients, attending the Inflammatory 
Bowel Disease (IBO) clinic at Groote Schuur Hospital, were recruited for this 
study. Following acquisition of informed consent (see Appendix 1), patients were 
randomized into 3 groups of 50 by means of a number draw. The random 
selection of the patients was to ensure that each group was Similar, and 
resembled the Crohn's disease population as closely as possible. Thus, the 
results of this study could be generalized to the population as a whole (Harris, 
1996). 
Permission to perform this study was obtained from the Research and Ethics 
committee, University of Cape Town (see Appendix 2). Good clinical practices 
(GCP) were maintained throughout the study and participants continued with 
their prescribed medication. Participants were assured of anonymity with regard 
to documentation of all data. Therefore, each participant was assigned a code 
number which was used instead of their names. 
3.1.2 Study Design 
The Kinesiology Group received a 60-minute Kinesiology session on a monthly 
basis for four months (four sessions). The Massage Group received a 60-minute 
Massage session on a montl~lly basis for four months (four sessions). The 
Control Group continued with their usual~linica' management, and medical 
therapy was continued as usual in all three groups. The three groups were 











the four-month intervention period and three-month follow-up to determine the 
















Four-month Post-intervention assessment 
1 
Three-month Follow-up assessment 












3.1.3 Inclusion Criteria 
At the time of enrolment participants had to: 
1. Have a definite diagnosis of Crohn's disease based on histologic or 
radiologic findings 
2. Be 18 years of age and above 
3. Have haq the disease for at least 5 years 
4. Be English speaking in order to comprehend the instructions on the 
questionnaires 
3.1.4 Review of Case Notes 




3. Date of birth (see Appendix 3) 
Medical History 
1. Date of diagnosis 
2. Extent of the disease 
3. The number and duration of clinical relapses in the last year 
4. The number of Crohn's related surgeries (see Appendix 3). 











3.2 PARAMETERS USED FOR THIS RESEARCH 
Disease activity was assessed by means of the Crohn's Disease Activity Index 
(COAl). Quality of life by means of the Short Inflammatory Bowel Disease 
Questionnaire (SIBOO), and psychological state by means of the Profile Of Mood 
States (POMS). A decrease in COAl indicates an improvement in disease 
activity and a decrease in POMS an improvement in psychological mood states, 
whereas an increase in SIBOO indicates an improvement in quality of life. 
3.2.1 Crohn's Disease Activity Index (COAl) 
The COAl is a numerical index of the patient's degree of illness designed to allow 
a systematic means of evaluating a patient's medical disease activity (Best, 
Becktel, Singleton & Kern, 1976). The COAl includes eight physiological 
measures related to Crohn's disease activity which are weighted and totaled to 
arrive at an activity index score (see Appendix 4 for a copy of the form). Index 
values of 150 and less are considered to indicate remission, values above 200 
and below 450 reflect an active disease process, and values above 450 suggest 
very severe disease activity (Best et al., 1976). Parenthetically, Best et al. (1976) 
state that they consider a cut-off value between active and remission to lie in the 
100 to 200 range. They chose the midpoint of 150 as a reasonable compromise. 
The COAl consists of 8 items. Information for items 1-3 was provided by the 
participants through their daily record on Symptom Recording Sheets (i.e. the 
frequency of loose stools, the extent of abdominal pain, and general well being) 
which were recorded during the seven days before their hospital visit. Items 4-8 
were provided by the attending physician from data gathered during the patient's 
examinations. It is important to note that activity is not synonymous with the 











because of various factors which results in the end state of the patient's clinical 
status in Crohn's disease (Teixeira & Ferguson, 1979, p,72). 
3.2.2 Short Inflammatory Bowel Disease Questionnaire (SIBDQ) 
Health-related quality of life (HRQOL) is an important determinant of health 
outcomes in chronic diseases such as inflammatory bowel disease (IBO). 
Disease-specific questionnaires are the most effective type of HRQOL 
instruments to define fluctuations in health status or response to treatment 
(Guyatt et aI., 1993). The Inflammatory Bowel Disease Questionnaire (IBOQ) 
has been valuable for assessing disease outcomes in patients with IBO (Mitchell 
et at, 1988; Guyatt et aI., 1989; Irvine et aI., 1994). However, administration, 
scoring, and interpretation of this questionnaire may be quite cumbersome for 
clinicians. Therefore, the Short Inflammatory Bowel Disease Questionnaire 
(SIBOQ), which is a shorter version of the IBOQ was used for this study (see 
Appendix 5). 
The SIBOQ, being a disease-specific, health-related quality of life questionnaire, 
has been specifically designed for practical use by community physicians to aid 
with the treatment of Crohn's disease (Irvine et aI., 1996). In the clinical setting, 
the IBOQ takes approximately 20 minutes to complete when interviewer-
administered, or 15 min when self-administered. Previous research has shown 
that results are valid for both self and interviewer administration (Mitchell et aI., 
1988; Guyatt et aI., 1989; Irvine et aI., 1994), It was estimated that after one test 
administration, patients could complete the SIBOQ in approximately 5 minutes. It 
can thus be noted that this method of assessing health status in Crohn's disease 
patients has the advantage of being short, easy to administer, and most 
importantly, easily understood by patients. 
The SIBOQ consists of 10 items. Each item is scored on a 7 -point graded scale 











"Some of the time"; 5= "A little of the time"; 6= "Hardly any of the time"; and 7= 
"None of the time". Absolute SIBOO scores thus range from 10 (poor HROOL) to 
70 (optimum HROOL) with 49-70 considered as normal. These items purport to 
measure Social, Emotional, Bowel, and Systemic functioning during the last two 
weeks prior to the patient's clinical visit. 
The SIBOO was generated from a large study population of 149 patients and was 
tested in two other populations to avoid bias. Since these scores were found to 
be valid, reliabte, and responsive to important clinical changes (Irvine et aI., 
1996), it seemed an appropriate choice for this research. 
The SIBOO was tested on one of the trials in which the IBOO was fully validated 
(Irvine et aI., 1994; Feagan et aI., 1994). The SIBOO explained over 90% of the 
variance of the IBOO and correlated very well (r range, -0.3 to -0.7) with disease 
activity indices in Grohn's disease. Mean SIBOQ scores differed in patients with 
active and inactive disease (discriminant validity) and gave comparable results 
among groups of Grohn's patients with similar disease severity (convergent 
validity). Gonsistent SIBOQ scores were maintained when no important changes 
in clinical status had occurred - of 141 patients with Grohn's disease who had 
not experienced a relapse by the first follow-up visit, the mean SIBOO scores 
were not significantly different from baseline, indicating good reliability. 
Interclass correlation coefficients were comparable for the SIBOO, IBOO, and 
disease activity indices, supporting their limited measurement error arid good 
test-retest reliability (Irvine et aI., 1996). 
3.2.3 Profile ~f Mood States (POMS) 
Evaluation of the adverse impact of Grohn's disease on patient's quality of life 
and the psychological distress related to them has been recognized as having 
great clinical importance. Previous studies (Porcelli et aI., 1994; Garrett et aI., 











distress to be a common psychological characteristic among patients with 
Crohn's disease. The present study sought to assess participant's distress to 
determine whether these levels of distress were affected by the treatment. 
The understanding of the psychology of emotions requires not only the inclusion 
of psychological and behavioural data but also subjective data of feeling and 
mood. To meet this need the POMS has been developed to measure six 
identifiable mood or affective states: Tension-Anxiety; Depression-Dejection; 
Anger-Hostility; Vigor-Activity; Fatigue-Inertia; and Confusion-Bewilderment. The 
POMS consists of a list of 65 adjectives. Respondents indicate the degree to 
which each adjective describe themselves during the last week using a 5-point 
Likert-Scale format. Standard scoring of the POMS provides a global distress 
score referred to as Total Mood Disturbance (TMD) as well as scores for the six 
subscales. Completion of the POMS takes approximately 3 to 7 minutes in 
healthy populations. Physically ill or otherwise compromised individuals may 
require up to 20 minutes to complete the POMS (Schacham, 1983). This could 
place an undue burden on an individual, particularly when the POMS is 
embedded in an assessment protocol consisting of multiple measures. 
For the purpose of this research the POMS-Short Form (POMS-SF: Shacham, 
1983) was used (see Appendix 6). The POMS-SF consists of 30 adjectives 
which an average individual can easily understand. Completion of t~lis scale 
takes approximately 3-5 minutes. As with the original POMS respondents 
indicate the degree to which each adjective describes themselves during the last 
week using a 5-point Likert-Scale format. Where 0= "Not at all", 1:: CIA little"; 2= 
"Moderately"; 3= "Quite a bit"; and 4= "Extremely". Each mood factor consists of 
5 adjectives. All items defined in each factor are keyed by adding one, except for 
the adjective "Efficient" in the confusion scale. This item receives a negative 
weight in calculating the factor scores. The Total Mood Disturbance score is 
obtained by adding the five scale scores of Anxiety, Confusion, Depression, 











scores (McNair et aI., 1992). The Total Mood Disturbance score gives a range 
from 30 (no distress) to 124 (severely distressed). 
The POMS-SF provides both an overall TMD score as well as scores from each 
of the six supscales contained in the original POMS. In the development of the 
POMS-SF, several items from each POMS subscale were eliminated on the 
basis of their impact on subscale internal consistency and face validity (Curran, 
Andrykowski & Studts, 1995). In a study using data collected fram 83 cancer 
patients, TMD and subscale scores from the POMS-SF were highly correlated 
with TMD and subscale scores from the POMS (all rs >.95). Internal consistency 
estimates of the POMS·SF scales using coefficient alpha ranged from .80 to .91, 
and internal consistency estimates using the original POMS scales ranged fram 
.74 to .91 (Curran et aI., 1995). These results suggest that the POMS-SF is an 
excellent alternative to the more time-consuming POMS - it preserves subscale 
information available in the original POMS without any :significant decrease in 
internal consistency. 
This scale has since been used to measure psychological distress in a variety of 
medical populations, including bone marrow transplant survivors (Baker, Curbow 
& Wingard, 1991), seriously ill patients and their families (Oye, Laudefeld & 
Jayes, 1990), and homosexual men with AIDS or AIDS-related complex (Mouton, 
Sweet, Temoshok & Mandel, 1987), 
3.2.4 Use of Tests 
The Crahn's Disease Activity Index is a published test and can be used freely for 
assessing Crohn's disease patients in a medical setting. The Short Inflammatory 
Bowel Disease Questionnaire and the Profile Of Mood States assessment test 
was purchased directly from the authors by the researcher. The researcher was 












3.3.1 Diary Card 
During the recruitment period, individuals meeting the inclusion criteria were 
given a diary card (see Appendix 7) which they had to complete daily during the 
7 days prior to their hospital visit. Instructions were given on how to complete the 
form. This data included: 
1. Number of liquid or very soft stools 
2. Abdominal pain (defined as none, mild, moderate, severe) 
3. General well-being (defined as generally well, slightly under par, poor, 
very poor or terrible) 
4. Use of diphenoxylate, loperamide or other opiates for diarrhea. 
3.3.2 Clinical Crohn's Disease Assessment 
The following information was provided by the attending physician after 
completion of the patient's routine examination 
1. The presence of abdominal mass (defined as none, questionable or 
definite) for the COAl calculation 
2. The presence or absence of known complications such as: 
a) Arthritis, arthralgia 
b) Eye problems: iritis, uveitis 
c) Skin conditions: erythema nodosum, pyoderma gangrenosum, 
aphthous stomatitis 
d) Anal fissure, fistula, or abscess 
e) Other fistulae 












3.4 PRE-TREATMENT DATA 
1. A nursing sister, who was blind to the group designation, took blood 
samples from each patient who was on the trial. The blood was send to 
the lab to be analyzed for the following results: 
a) Haematology: full blood count, ESR 
b) Biochemistry: Iron, Magnesium, Calcium, Liver profile (see 
Appendix 8) 
2. Each patient was weighed in light street clothing by the same nursing 
sister 
3. Height was measured in stocking feet and the Body Mass Index 
(BMI=weightlheight 2) was then calculated from this data 
a) BMI of less than or equal to 16kg/m2 was considered severely 
malnourished 
b) BMI of between 16 and 19k9/m2 was considered to be moderately 
malnourished 
c) BMI of between 19 and 25kg/m2 was in the normal range 
d) BMI between 25 and 30kg/m2 was considered overweight 
e) BMI of greater than 30kg/m2 was termed obese 
4. A Clinical Disease Activity Index (COAl) was completed by using the data 
from the patient's diary card together with data from the clinical Crohn's 
disease assessment 
5. The Short Inflammatory Bowel Disease Questionnaire was completed 
6. A Profile Of Mood States (POMS-SF) was also completed by each patient 
7. Another diary card was given to each patient to take home to be filled out 












Questionnaires were issued to the patients by the same nursing sister who took 
their blood samples. Patients then completed these questionnaires while waiting 
on the physician for their routine examination. The information recorded in their 
folders by the physician, was require to complete the COAL The completed 
questionnaires were returned to the nursing sister . 
• 
At time of entry into the study, patients were assessed as either Active (COAl 
>200), Quiescent (COAI<150) or Indeterminate (COAl 150-200). In this way it 
could be determined whether therapy had an effect on improving disease activity 
(in the Active Group) or in maintaining remission (in the Quiescent Group). 
Patients in the Kinesiology Group received their Kinesiology sessions on 
alternate days to the Massage. By scheduling Kinesiology and Massage 
Sessions on different days, it was hoped that patients in the Massage GrouP. 
while waiting for their therapy session, would not discuss their therapy with a 
patient receiving Kinesiology or vice versa. 
3.5 THERAPY 
The Kinesiology and the Massage therapy were conducted in a room adjacent to 
the consulting room of the attending physician at Groote Schuur Hospital. The 
Kinesiology and the massage therapy were implemented by the researcher who 
is a registered Kinesiologist as well as a registered Massage therapist. These 
therapy sessions were conducted on the same day when patients attended the 
GIT clinic for their monthly check-ups to alleviate unnecessary disruption to their 
routine. 
Patients in the Kinesiology and the Massage Group were told that they would be 
receiving a 60 minute massage session on a monthly basis for four months (4 
sessions in total) to release the stress from their bodies. None of these patients 
were aware of the difference in therapies. The Control Group was managed in 











3.5.1 Kinesiology Group (First Session 60 Minutes) 
Step 1: Correction of Neurological Disorganization 
Before commencing with the actual therapy, it is believed, from a Kinesiological 
perspective, as essential to rectify the body's electrical charge in order to ensure 
accurate muscle monitoring. To correct side-to-side electromagnetic switching 
problems the left hand is placed on the navel. This is believed to bring attention 
to the gravitational center of the body and is also believed to stimulate the core 
muscles, situated in this area, which are important contributors to body balance. 
The right hand gently rubs the indentations between the first and second ribs, 
directly under the clavicle, to the right and left of the sternum using the thumb 
and middle 'finger. It is believed that this procedure enhances blood flow to the 
brain. Since the right hemisphere of the brain controls the left side of the body 
and vice versa, right side/left side polarity imbalance is assumed to be rectified. 
The process is repeated by changing over of hands (Hannaford, 1995). 
To correct top and bottom electromagnetic switching problems, the left hand is 
placed over the navel while the right hand rubs acupressure points above the top 
and below the bottom lip. The Central meridian, which is believed to provide 
energy to the front of the body, is assumed to flow from the pubic bone upwards 
ending underneath the bottom lip. The Governing meridian, which is believed to 
provide energy to the back of the body, is assumed to flow from the coccyx up 
the spine, over the head ending above the top lip. Rubbing these two 
acupressure points is believed to rectify top and bottom polarity imbalance. The 
procedure is repeated by changing over of hands (Gralton & Gralton, 1998). 
Front and back electromagnetic switching problems are rectified by placing the 
left hand on the navel while the right hand rubs the acupressure point which is 











hands so that the right hand is placed on the navel while the left hand rubs the 
acupressure point on the coccyx (Gralton & Gralton, 1998). 
Step 2: Assessing for an accurate indicator muscle 
Checking for an accurate indicator muscle, usually the anterior deltoid, is very 
important for correct assessment of restricted or blocked energies in the body. 
The testee is asked to raise both arms straight to about 30° in front of the body. 
The tester now pushes on both arms, above the wrists, to move them back to the 
sides of the body, using less than 1 kilogram of pressure, for about 2 seconds to 
see if the muscle produces a locked response. The arms will either stay firm and 
"lock" or feel weak and "unlock". If the muscle unlocks, the fingers of the one 
hand is placed on top of the head while using the other hand to rub the third, 
fourth, and fifth rib spaces beside the breastbone on the front of the chest (these 
are the acupressure points related to this muscle). The muscle should now lock, 
and is suitable to be used as an accurate indicator muscle for assessing 
compromised areas (restricted flow of energy) in the body (Diamond, 1985). 
Step 3: Assessing the body's energy level 
It is believed, when energy to the brain is compromised, poor concentration, 
confusion and vagueness result. The Central meridian energy flow must 
therefore be checked. The tester flushes the meridian by brushing the hand up 
and down several times, ending with two or three traces from the crotch to the 
bottom lip. The muscle of the forearm is assessed for a "locked' response. If the 












Step 4: Fourteen Muscle Assessment 
The 14 muscles, which are related to the 14 major meridians in the body, are 
assessed. An unlocked muscle response will indicate a restriction in the energy 
flow of the related meridian which will have to be corrected by means of a 
Neurolymphatic massage, Spinal reflex stimulation, Neurovascular stimulation or 
and Emotional Stress Defusion. 
Step 5: Neurolymphatic Stimulation 
The Neurolymphatic or Chapman Reflex Points, located on the front of the body, 
are stimulated when required, to increase and enhance the flow of energy. 
Step 6: Spinal Reflex Stimulation 
If the muscle weakness is bilateral, the Spinal Reflex Points should be stimulated 
first. These points are located on the spine itself. The involved spinal reflex 
point is rubbed up and down the vertebrae, covering one or two levels above and 
below the actual point. If the muscle test still indicates an unlocked response, 
the Neurovascular Holding Points would be the next option. 
Step 7: Neurovascular Holding Points 
The Neurovascular Holding Points (Bennett Reflex POints) are located mainly on 
the head. By. holding the appropriate acupressure point, the neuronal 
associations and acupuncture meridians are stimulated. This in turn, promotes 
increased blood flow to the muscle and the related organ or gland. The 
previously unlocked muscle should now lock when tested. This procedure (side-
to-side, top-to-bottom, front-to-back switching; muscle monitoring; 











points) concludes the first therapy session which usually lasts 60 minutes (the 
third and fourth session will be the same as the first session). 
Emotional Stress Oefusion (ESO) (Second Session 60 Minutes) 
During this session the patient is questioned about the most stressful/emotional 
issue at this point in his/her life. To evoke the emotional context of that 
experience, the patient is asked to think about the issue. A muscle is monitored 
to ascertain if any subconscious stress exists pertaining to this issue. If the 
muscle unlocks, it would be an indication that there is indeed unresolved 
subconscious stress, related to the issue, present. While the patient continues to 
think about the stressful issue, the Kinesiologist holds the ESO points, which are 
situated on the forehead above each eye brow, and re-monitors the muscle after 
a while. If the muscle locks, it indicates a change in response. In other words, 
thinking of the stressful issue created an energy frequency of imbalance. 
Holding the ESO points on the forehead also activates an energy frequency. If 
the energy frequency of the stress matches the energy frequency of the ESO 
points, the muscle will lock. If the muscle does not lock the ESO points should 
be held longer until the different frequencies vibrate in harmony with each other 
(Krebs, 1998). 
If the issue is of an emotional nature and is causing an imbalance in the patient's 
bodily function, the Kinesiologist will assess for the origin of a problem by 
implementing the age recession process. To determine the time and origin of 
this emotional stress, the Kinesiologist has the patient state "present" and 
monitors the muscle. No change in the muscle response indicates that there is 
no energy frequency match. The patient says "future". If there is still no muscle 
change the patient says "past". A change in' the muscle indicates that the origin 
of this emotional issue is in the patient's past. Starting with the current age and 
working back towards birth, the patient says each year while the Kinesiologist 











muscle is an indication that the cause of the emotional response, in the current 
circumstance, originates from something that occurred between birth and the 
specific age when the muscle unlocked. The patient repeats the year and age. 
While doing this, it is believed that the limbic brain immediately inspects all 
experiences at that age for their emotional content. Simultaneously it is also 
• 
assessing how they relate to the current issue. In the subconscious, what is 
triggered from memory is "now" and those same neuropathways that were 
activated during the original event become active once again. The ESO 
procedure is applied until the energy frequencies, pertaining to this particular 
emotional issue, is balanced. 
Further information regarding the emotional issue is gained via muscle 
monitoring to determine who was relevant at the time, a male or a female. The 
specific emotion evoked at the time is also ascertained. To locate the meridian 
most out of balance, the alarm point for each meridian is assessed. Because the 
energy flow in each meridian is disturbed or unbalanced by a different type of 
emotion, the alarm point that unlocks the muscle being monitored when touched, 
reveals the nature of the emotion associated with the issue {see Appendix A for 
table of meridian-related emotions}. The ESO technique is applied to assist the 
patient in resolving the causal issue by holding the acupressure pOints on the 
frontal eminences. After a while, the synchronous pulsing in both points on the 
forehead is believed to indicate that the subconscious and conscious review of 
the past has defused the stress from the original event. Finally, the muscle is 
monitored as the patient states the ages from the year when the issue had 
occurred to the current age. If there is no further muscle response, the issue has 
been cleared. 
The Emotional Stress Oefusion experience ,(aries with each individual and with 
each issue dealt with. Some people recall infinite detail of an experience while 
others become emotional to· the point of tears. The end result is usually 











3.5.2 Massage Group 
Massage was selected as a therapy for the Massage Group. Since massaging 
also involves physical touch as with Kinesiology, it was thought to be appropriate 
as a comparison for control purposes in this study. Massage is believed to have 
direct psychological and physiological benefits. Physically, massage increases 
metabolism, relaxes and refreshes the muscles, and facilitates the function of the 
lymphatic system. It also improves circulation of blood, thereby improving the 
delivery of oxygen and nutrients to the cells as it enhances the removal of 
metabolic wastes. Massage therapy is believed to be effective in the 
management of pain (Greene, 1997). 
Psychologically, massage relieves fatigue, reduces tension and anxiety, calms 
the nervous system, and promotes a sense of relaxation, renewed energy, and a 
feeling of well being (Greene, 1997). 
First Session (60 Minutes) 
Step 1: The back 
The back was massaged by first working broadly over the whole area then 
concentrating on the smaller portions in turn - shoulder blades and upper back, 
lower back, and finally the spine itself. 
Step 2: Back of legs 
The legs were massaged from the bottom up, working each leg separately, and 











Step 3: Shoulders, neck and scalp 
On the front of the body the shoulders were massaged, working on both front and 
back simultaneously. Turning the head to one side each shoLilder was then done 
separately ending with a full scalp stimulation. 
Step 4: Face 
A full facial massage was done starting from the forehead down to the chin 
working outward from the center to the sides 
Step 5: Arms and hands 
Each arm was massaged separately. Working up the limb, draining it, then down 
the limb using a kneading method and ending with the wrist and hand. 
Step 6: Front of torso 
After focusing on the ribcage and sides of the torso, the abdomen and belly area 
was massaged very gently using long sweeping strokes. Special care was taken 
not to cause any discomfort since these were very tender areas in Crahn's 
disease patients. The aim was to release and not create stress. 
Step 7: Front of legs 
As for the back of the legs, the front was massaged from the bottom up to drain 
the leg, circling the kneecap during the process, and down again using a 











Step 8: Connecting 
Finally, all parts of the body were linked using long "connecting" Strokes. 
The second, 'third, and fourth sessions were the same as the first session. 
3.6 POST-TREATMENT DATA 
1. A second blood sample was taken from each patient. 
2. The blood was send to the lab to be analyzed for the following results: 
a. Haematology: full blood count, ESR 
b. Biochemistry: Iron, Magnesium, Calcium, liver profile 
3. Each patient was weighed in light street clothing by the same nursing 
sister 
4. Height was measured in stocking feet and the BMI was then calculated 
from this data 
S. A Clinical Disease Activity Index (COAl) was completed by using the data 
from the patient's diary card together with data from the clinical Crohn's 
disease assessment 
6. The Short Inflammatory Bowel Disease Questionnaire was completed 
7. A Profile Of Mood States (POMS-SF) was also completed by each patient 
8. Another diary card was given to each patient to be filled out at home on a 












3.7 THREE-MONTH FOLLOW-UP 
1. A third blood sample was taken from each patient. 
2. The blood was send to the lab to be analyzed for the following results: 
a. • Haematology: full blood count, ESR 
b. Biochemistry: Iron, Magnesium, Calcium, Liver profile 
3. Each patient was weighed in light street clothing by the same nursing 
sister 
4. Height was measured in stocking feet and the BMI was then calculated 
from this data 
5. A Clinical Disease Activity Index (COAl) was completed by using the data 
from the patient's diary card together with data from the clinical Crohn's 
disease assessment 
6. The Short Inflammatory Bowel Disease Questionnaire was completed 











3.8 DATA ANALYSIS 
At the end of the final assessment all questionnaires were scored by an 
independent medical doctor. The data from these questionnaires as well as the 
blood results were coded and captured into Microsoft Excel 7.0 (see Appendix 9 
for lists of data). The disk containing the raw data was handed to a statistician for 
computation. Data was analyzed using the Statistica for Windows computer 
package. 
A series of i-tests was applied to the data collected at the pre-intervention 
observation to determine whether the Kinesiology, Massage and Control Groups 
differed significantly on the demographic and dependent variables under study. 
The groups were compared on pre-treatment, post-treatment and three-month 
follow-up differences on each variable using analysis of variance. The mean 
scores of these calculations were presented in table form and also as box and 
whisker plots. In addition, the significance of pre-treatment, post-treatment, and 
three-month follow-up changes within each group was analyzed through analysis 
of variance, Given the large number of tests, post-hoc comparisons were done 
using Scheffe's statistical test which is considered conservative (Howell, 1997), 
Due to the unpredictable nature of Crohn's disease, patients were at varying 
levels of disease activity and were therefore stratified into those with an active 
disease (CDAI>200), quiescent (CDAI<150), and indeterminate disease (CDAI 
150-200), Assessments were done separately according to these sub-groupings. 
The correlations between the ESR, CDAI, SIBDQ, and POMS scores taken at 
pre-treatment, post-treatment, and follow-up observations were presented in the 
form of scatterplots. 














4.1 -PATIENT CHARACTERISTICS 
In the absence of a prior estimate, using an a value of 0.05 to achieve a power of 
90%, a sample size of 50 (total N=150) was calculated as sufficient to 
demonstrate a significant difference (Howell, 1997). Therefore, 150 consecutive 
Crohn's disease patients were studied. These patients were randomly assigned 
to three groups: Control Group {N=50}, Massage Group (N=50), and Kinesiology 
Group (N=50). All partiCipants remained on the program for the entire duration of 
the research. 
4.1.1 Age 
The mean age of the Control Group was 41.50 ± 13.49, in comparison to the 
Massage Group with a mean age of 43.32 ± 12.40, and the Kinesiology Group 
with a mean age of 44.04 ± 11.96. The mean age of the group was 42.95 ±12.59 
years (Table 3). 
Table 3: Age 
Group N Mean Std. Dev. 
Control 50 41.50 13.49 
Massage 50 43.32 12.40 
Kinesiology 50 44.04 11.96 
All Groups 150 42.95 12.59 











4.1.2 Sex Distribution Between Groups 
The Control Group consisted of 14 (28%) males and 36 (72%) females in 
comparison to a Massage Group with 13 (26%) males and 37 (74%) females and 
a Kinesiology-Group with 15 (30%) males and 35 (70%) females (Table 4). 
Table 4: Sex Distribution Between Groups 
Group Male Female 
Control (%) 14 (28%) 36 (72%) 
Massage (%) 13 (26%) 37 (74%) 
Kinesiology (%) 15 (30%) 35 (70%) 
There was no significant difference in sex distribution between the groups ( X2(2) 











4.1.3 Body Mass Index (BMI) 
At entry, 38% of the patients had 8MI values greater than 25 kg/m2 (Table 5). 
21.33% were overweight and 25% were· obese. 53% of the patients were of 
normal weight, 9.39% were - under weight with 8.6% being moderately 
malnourished and 1.33% severely malnourished. 
Table 5: Body Mass Index (kg/m2) 
< = 16 16-19 19-25 25-30 >30 
Entry 2(1.33%) i 13(8.6%) 78(53%) I 32(21.33%) 25(16.67) 
Post-trmt 1(0.67%) 15(10%) 75(50%) 37(24.67%) 22(14.67%) 
Follow-up 2(1.33%) 13(8.67%) 73(48%) 39(26%) 23(15.33%) 
8MI of greater than 30 is obese, 25-30 is overweight, 19-24.9 is normal. 16-18.9 
is undernourished (moderately malnourished) and 8MI below 16 is severe 
malnutrition (Roche Diagnostics, 2000). 
Table 6 illustrates the 8MI values between groups across the three treatment 
levels. 
Table 6: Body Mass Index (kg/m2) Between Groups 
Group Entry . i Post-treatment Follow-up 
Control 24.60 ± 5.77 24.59 ± 5.67 24.41 ± 5.73 
Massage 25.81 ± 6.49 25.95 ± 6.28 25.90 ± 6.13 
i KinesioJogy 24.82 ± 5.48 25.15 ± 5.49 25.49 ± 5.71 
Results = mean ± standard deviations (SO). 
There were no significant differences in 8MI values between groups across the 











4.1.4 Duration of Disease 
Duration of the disease in years is illustrated in Table 7. The Control Group had 
a mean duration of 11.62 ± 5.83 in comparison to a Massage Group with a mean 
of 12.70 ± 6.52 and Kinesiology Group with a mean of 13.34 ± 5.85. The mean 
duration of disease of the whole group was 12.5 ± 6.08 years. 
Table 7: Duration of Disease 
'-.. 
Group N . Mean (years) SO 
Control 50 11.62 5.83 
Massage 50 12.70 6.52 
i Kinesiology 50 13.34 5.85 
All Groups 150 12.55 6.08 
There was no significant difference in duration of the disease between the groups 
(F=1.02; p=0.36). 
4.1.5 Site of Disease 
The disease location was assessed as ileal, colonic, and ileocolonic. Table 8 
illustrates the distribution of the disease location between the groups. Of the 
whole group, twenty two patients had ileitis, twenty seven had colitis, and one 
hundred and one patients had ileocolitis 
Table 8: Site of Disease 
Group ileitis colitis ileOCOII~ 
Control (%) 8 (16%) 9 (18%) 33 (66%) 
Massage (%) 6 (12%) 10 (20%) i 34 (68%) 












There was no significant difference in the disease location between the groups 
(x2 (4) = 0.60; p=0.96). 
4.1.6 Disease Activity 
At entry, 48 patients were in remission (COAI<150), and 87 had ~vidence of 
active disease (COAI>200). Table 9 illustrates the distribution of disease activity 
between the groups. 
Table 9: Disease Activity Between Groups as Measured by the COAl 
Group CDAI<150 CDAI=150-200 CDAI>200 
Control 23 (85.65±42.79) 6 (177.03±13.69) 21 (315.86±92.72) 
Massage 16 (103.81±31.20) 6 (179.65±12.96) 28 (307.34±86.32) 
Kinesiology 9 (1 02.76±29. 12) f3 (178.57±8.47) 38 (306.38±7B.01) 
n(mean COAl ± SO) 
Although there were significantly more active patients in the Kinesiology Group 
(X2(4)=12.35; p=0.01), mean COAl scores were similar in the three groups, and 












4.1.7 Disease Relapse Rates 
Fifty percent of the sample had experienced one or more active episodes in the 
year preceding the study (Table 10). 
Table 10: Relapse Rates in the Preceding Year 
Group Patients with relapses % of group _. 
Control 22 44.00% 
Massage 24 48.00% 
Kinesiology 29 58.00% 
All Groups 75 50.00% 
There was no significant difference in the number of relapse rates, experienced 
during the year preceding the study, between the groups (';(2(2) = 2.08; p= 0.35). 
Table 11 illustrates the actual relapse rates experienced by the groups during the 
year preceding the study. 75 Patients had no relapses, 43 had 1 relapse, 22 had 
2 relapses, and 10 had 3 relapses in the preceding year. 
Table 11: Breakdown of Groups by Actual Relapse Rates in the Year 
Preceding the Study 
Groups 0 1 2 3 
Control (%) 28 (56%) 15 (30%) 5 (10%) 2 (4%) 
Massage (%) 26 (52%) 17 (34%) i 5 (10%) 2 (4%) 
Kinesiology (%) 21 (42%) 11 (22%) 12 (24%) 6 (12%) 
Totals 75 43 22 10 
There was no significant difference in relapse rates between the groups (';(2(6) = 











4.1.8 Disease Related Surgical Procedures 
Prior to the intervention period, 94 (63%) of patients had undergone one or more 
disease related surgical procedures. The results are illustrated in Table 12. 
Table 12: Disease Related Surgical Procedures 
Group No. of patients % of group 
Control 33 66.00% 
. Massage 32 64.00% 
Kinesiology 29 i 58.00% 
All groups 94 63.00% 
Table 13 illustrates the breakdown of the groups by actual number of disease 
related surgeries. 56 Patients had no surgery, 48 had 1 surgery each, 28 had 2, 
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There was no significant difference in disease related surgical procedures 




















The number of patients with active Grohn's disease in each group, who were on 
steroids during the study period, is illustrated in Table 14. 
Table 14: 
Patients with Active Crohn's Disease Using Steroids During the Study 
Period 
Group N Steroids No Steroids 




Kinesiology 50 I 5(10%) 45(90%) 
During the study, 9 (18%) patients with active disease in the control group, 7 
(14%) in the massage group and 5 (10%) in the Kinesiology group received 
steroids for their active disease. There was no significant difference between the 
groups (x2(2)=1.14; p=0.56). None of the patients with quiescent disease nor 
those patients with a GOAl score of >150 and <200, required the use of steroids. 
The number of patients with active disease in each group, who were on 
immunosuppressives during the study period, are illustrated in Table 15. 
Table 15: Patients with Active Disease Using Immunosuppressives During 
the Study Period 
Group I N Azathioprine No Azathioprine 
Control 50 8{16%) 42(84%) 
Massage 50 8(16%) 42(84%) 











During the study, 8 (16%) of patients with active disease in the Control Group, 8 
(16%) in the Massage Group, and 9 (18%) il1 the Kinesiology Group were taking 
immunosuppressive medication (Azathioprine) for their active disease. !'Jone of 
these patients were on 5-ASA or any other form of immunosuppressive 
medication during the study. Ther:.e wece no significant differences in the use of 
medication between groups, prior and during the study (x2(2)=O.08; p=O.96). 
The patients' demographic data on entry into this study indicate that all groups 
were of similar age, sex, and 8MI. Disease related data illustrate that there were 
no significant differences between duration and site of the disease between the 
groups. Although there were significantly more patients with active Crohn's 
disease in the Kinesiology Group on entry, the mean COAl scores were similar in 
the three groups. The groups were therefore considered probabilistically 











4.1.10 Patients' Haematological and Biochemical Characteristics 
at Entry into Study 
The haematological and biochemical characteristics of patient~ with active 
Crohn's disease at entry are illustrated in Table 16. 
Table 16: Characteristics of Patients with Active Disease at Entry into 
Study 
Control Massage Kinesiology 
• HB (g/dl) 12.09 ± 1.90 13.16 ± 1.67 12.83 ± 1.75 
HCT (III) 0.38 ± 0.05 0.42 ± 0.07 0.40 ± 0.05 
ESR (mm/hr) 29.76 ± 25.15 26.25 ± 22.59 26.05 ± 21.97 
IRON (U/L) 8.14 ± 4.33 10.46 ± 5.22 11.58 ± 6.97 
• CALC (mmoIlL) 2.33 ± 0.14 2.36 ± 0.12 2.34 ± 0.16 
MAG (mmoI/L) .0.77 ± 0.09 0.77 ± 0.09 0.74 ± 0.08 
TBR (umoI/L) 6.71 ± 4.36 6.61 ± 3.47· 7.39 ±4.30 
ALT (U/L) 118.71 ± 10.17 .! 17.39 ± 10.06 19.65 ± 13.72 
ALK PHOS (UII) 104.09 ± 36.63 102.61 ± 37.89 l1 01.37 ± 42.53 
Results = mean ± standard deviations (SO). 
At entry, active patients in the Control Group presented with a mean 
haemoglobin (HB) level of 12.09 ±1.90 gldl (normal range = 11.6-1.5.6 g/dl), 
hematocrit (HCT) 0.38 ± 0.05 III (normal range = 0.37-0.53 III), and a mean IRON 
level of 8.14 ± 4.33 U/L (normal range = 7-26 U/L). The Massage and the 
Kinesiology Groups were all within the laboratory normal range (Roche 
Diagnostics, 2000). The erythrocyte sedimentation rate (ESR) in all three groups 
was above the normal range (1-10 mm/hr), but there were no significant 












None of the active patients had evidence of significant abnormal biochemical 
scores at entry. The Control Group presented with a mean calcium (CALC) level 
of 2.33 ± 0.14 mmollL (normal range = 2.1-2.6 mmollL), magnesium (MAG) of 
0.77 ± 0.09 mmol/.L (normal range = 0.70-1.00 mmollL), total Bilirubin (TBR) 6.71 
± 4.36 U/L (normal range = 1-17 umol/L), alanine transaminase (AL T) 18.71 ± 
10.17- U/L (normal range = 1-41 U/L), alkaline phosphatase (ALP) 104.09 ± 
36.63 U/L (normal range = 39-117 U/L). The biochemical results in the Massage 
and the Kinesiology Groups were similar and were within the laboratory normal 











The haematological and biochemical characteristics of patients with quiescent 
Crohn's disease at entry are illustrated in Table 17. 
Table 17: Characteristics of Patients with Quiescent Disease at Entry into 
Study 
I Control Massage Kinesiology 
HB (g/dl) 12.96 ± 1.95 13.32 ± 1.20 13.55 ± 1.80 
HCT (III) 10.45 ± 0.23 0.40 ± 0.03 0.42 ± 0.04 
ESR (mm/hr) 18.48 ±14.77 24.94 ± 15.84 13.89 ± 15.32 
IRON (U/L) 10.43 ± 5.23 12.06 ± 6.99 13.67 ± 4.24 
CALC (mmollL) 2.35 ± 0.12 2.33 ±0.08 2.38 ± 0.13 
MAG (mmoIlL) 0.81 ± 0.62 0.76 ± 0.06 0.76 ± 0.06 
TBR (umollL) 7.65 ± 2.76 7.19±3.41 8.67 ± 6.32 
ALT (U/L) 23.56 ± 21.87 27.69 ± 33.40 16.67 ± 9.38 
ALK PHOS (U/I) 85.91 ± 27.49 127.31 ± 113.72 85.22 ± 33.61 
Results = mean ± standard deviations (SO). 
At entry, the mean HB, HCT, IRON, CALC, MAG, TBR, and AL T levels in the 
quiescent patients were all within the laboratory normal range. Although patients 
were· assessed as quiescent in terms of the COAl, the mean ESR was slightly 
increased. However, there were no significant differences in ESR levels between 
the groups (F=1.67; p=0.19). Mean ALK PHOS levels in the Massage Group 
were a/so above the normal range at 127.31 ± 113.72 U/I (normal range = 39-
117 Uti) compared to the Kinesiology Group with a mean ALK PHOS level of 












The haematological and biochemical characteristics of patients with COAl 150-
200 at entry are illustrated in Table 18. 
Table 18: Characteristics of Patients with ~DAI150.200 at Entry into Study 
Control - Massage Kinesiology 
HB (g/dl) 12.55 ± 1.90 12.60±1.11 12.20 ± 0.87 
) 0.39 ± 0.05 0.39 ± 0.01 0.38 ± 0.02 
ESR (mrnlhr) 24.00 ± 22.99 31.17 ± 18.90 27.33 ± 32.81 
IRON (U/L) 7.33 ± 3.93 10.33 ± 5.12 6.00 ± 4.36 
CALC (mmoIlL) 2.35 ± 0.10 2.37 ± 0.09 2.33 ± 0.12 
MAG (mmoIlL) 0.78 ± 0.04 i 0.81 ± 0.07 0.79 ± 0.18 
TBR (umoIlL) 8.50 ± 5.58 5.67 ± 2.34 6.33 ± 2.08 
ALl (U/L) 20.00 ± 13.19 25.50 ± 15.82 14.33 ± 9.24 
ALK PHOS (UII) 119.50 ± 92.73 112.33 ± 30.39 84.33 ± 28.54 
Results = mean ± standard deviations (SO). 
Patients with COAl between 150-200, presented with mean HB, HCT, IRON, 
CALC, MAG, TBR. AL T, and ALK PH OS levels which were all within the 
laboratory normal range. However, the mean ESR levels in all three groups were 
above the normal range (1-10 mm/hr). The mean ESR level of the Control Group 
was 24.00 ± 22.99 mm/hr, Massage Group 31.17 ± 18.90 mm/hr, and the 
Kinesiology Group 27.33 ± 32.81 mm/hr. There were no significant differences in 
mean ESR levels between the groups (F=0.14; p=0.87). The ESR levels of the 
three groups were significantly positively associated with COAl scores (r=0.247; 
p= 0.002) at entry (Figure 14). 
At entry into the study the three groups were probabilistically equivalent on all 
haematological and biochemical levels (eg. HB, HCT, ESR, IRON,CALC,MAG, 












4.2 CROHN'S DISEASE ACTIVITY INDEX (COAl) 
4.2.1 Patients with Active Crohn's Disease (COAl >200) (n=87) 
" Bo}(Plotm~tratin9COAIScoresof,Active Patients. ' 
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Figure 11: COAl of active patients in the three groups at entry, post-
treatment, and follow-up. 
Table 19 illustrates the mean COAl of patients with active Crahn's disease at 
entry, post-treatment, and follow-up. 
Table 19: Mean COAl of Patients with Active Crohns' Disease 
Entry Post-treatment Follow-up 
Control 315.86 ± 92.72 285.93 ± 107.94 264.26 ± 109.64 
Massage 307.34 ± 86.32 253.26 ± 110.46 236.50 ± 100.61 
Kinesiology 306.38 ±78.01 176.99 ± 93.63 152.34 ± 90.23 











At entry mean COAl scores were similar in the three groups (Controls 315.86 ± 
92.72; Massage 307.34 ± 86.32; and Kinesiology Group 306.38 ± 78.01) (Figure 
11). Following a four-month intervention period, mean COAl scores were 
reduced in the Kinesiology Group (176.99 ± 93.63) and in the Mass?ge Group 
(253.26 ± 110.46) whereas the Control Group was unchang~d (285.93 ± 107.94). 
At three-month follow-up, a further reduction in the mean COAl scores was 
evident in the Kinesiology Group (152.34 ± 90.23) as well as .in the Massage 
Group (236.50 ± 100.61) whereas the Control Group remained unchanged 
(264.26 ± 109.64). 
Table 20: Two-way ANOVA Illustrating Repeated Measures of Active COAl 
55 df M5 F P 
GROUP 302897.88 2 151448.94 9.10 0.0002 
TREAT 379137.64 2 189568.82 35.98 1.038E-13 
TREA T*GROUP 114105.27 4 28526.31 5.41 0.0004 
The results of the ANOVA statistic indicate that the mean COAl levels are 
significantly different across the stage of treatment (F=35.98; p<0.001). This 
result is irrelevant since this is mean over duration of the entire study. The mean 
COAl levels are also significantly different between the treatment groups 
(F=9.10; p<0.001). In this instance it is expected that regression to the mean will 
occur and thus the treatment main effect could be an artifact therefore, this effect 
will not be interpreted. 
The interaction variable TREAT*GROUP indicates that at least one treatment 
type has caused a significant change in COAl levels (F=5.41; p<0.001) (Table 
20). For more conclusive evidence, the TREAT*GROUP interaction is formally 












Table 21: Scheffe's Test For Assessing TREA T*GROUP interaction 
Group Entry Post-treatment Follow-up 
Control 315.86 285.93 264.26 
Massa9-e 307.34 253.26 2~6.50 -
Kinesiology 306.38 176.99 * 152.34 ** 
*p<0.001 vs entry; ** p<0.001 vs entry 
The mean CDAI level in the Kinesiology Group is significantly lower at post-
treatment level (p<0.001) and follow-up (p<0.001) compared to entry (Table:21) .. 
Although the mean CDAI level in the Massage and Control Groups presented 
with some change at post-treatment and follow-up stages, the results are not 
significant and probably due to regression to the mean. 
Patients were also assessed in terms of proportion achieving a clinical response 
(as indicated by a fall in COAl of ~70 points) and those achieving remission 
(CDAI<150). 
Table 22: Active Patient's Disease Activity at Post-treatment Stage 
Groups N ~70 Points CDAI<150 CDAI>200 
Control 21 4 (19%) 3 (14%) 16 (76%) 
Massage 28 9 (32%) 7 (25%) 16 (57%) 
i Kinesiology 38 25 (66%) 19 (50%) 10 (26%) 
I 
• 
At the four month visit, the Control Group consisted of 21 patients with active 
disease, the Massage Group had 28, and the Kinesiology Group had 38 patients. 
Following the four-month intervention period, 4(19%) patients with active disease 
in the Control Group, 9(32%) in the Massage Group, and 25(66%) in the 
Kinesiology Group had a reduction of ~70 points in their COAl score. 10(26%) of 











to the Massage Group with 16(57%), and the Control Group with 16(76%) of 
patients who remained in an active disease state. 19(50%) patients in the 
Kinesiology Group went into clinical remission compared to 7(25%) in the 
Massage Group and 3(14%) in the Control Group (Table 22). Although 
numerically more patients in the Massage Group compared to the Controls 
achieved ciinical response and remission, the differences did not achieve 
significance. Significantly more patients in the Kinesiology Group achieved 
ciinical response (X;2(4) = 11,82; p<O.001) and remission (;e(4) = 7.38; p<O.01). 
Table 23: Active Patient's Disease Activity at Follow~up 
Groups N ~70 Points CDAI<150 CDAI>200 
Control 21 1 (4%) 2 (9%) 15 (71%) 
Massage 28 6 (21 %) 9 (32%) 17 (60%) 
Kinesiology 38 21 (55%) 19 (50%) 10 (26%) 
At three-month follow-up, 1 (4%) patient in the Control Group, 6(21 %) in The 
Massage Group, and 21 (55%) in the Kinesiology Group had a further reduction 
of 70 points in their CDAI scores (Table 21). 15(71%) of patients in the Control 
Group, 17(60%) in the Massage Group, and 10(26) in the Kinesiology Group 
remained in an active disease state while 2(9%) in the Control Group, (32%) in 
the Massage Group, and 19(50%) in the Kinesiology Group went into clinical 
remission (COAl <150) (Table 23). Although more patients in the Massage 
Group, compared to the Controls achieved clinical response and remission, the 
differences did not achieve significance. Significantly more patients in the 
Kinesiology Group achieved clinical response (X;2(4)=14.75; p<0.001) and clinical 












4.2.2 Patients with Quiescent Crohn's Disease (COAl <150) n=48 
Sox Plot Illustrating CPAI Scores ofQuiescentPatien~s. 
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Figure 12: COAl of quiescent patients in the three groups at entry, post-
treatment, and follow-up. 
Table 24 illustrates the mean COAl of patients with quiescent disease at entry, 
post-treatment, and follow-up. 
Table 24: Mean COAl of Patients with Quiescent Crohn's Disease 
Entry Post-treatment Follow-up 
Control 85.65 ± 42.79 121.29 ± 89.43 161.24 ± 93.45 
Massage 103.81 ± 31 .20 129.75±81.18 147.06 ± 79.20 
Kinesiology 102.76 ± 29.12 97.95 ± 50.40 110.90 ± 89.12 











In patients with quiescent disease, the Control Group presented with an increase 
in mean COAl scores at both post-treatment (121.29 ± 89.43) as well as follow-
up (161.24 ± 93.45) compared to the mean COAl scores at entry (85.65 ± 42.79). 
The Massage Group presented with an increase in mean COAl scores at follow-
up level (147.06 ± 79.20) compa.red t9 entry (103. 81 ± 31.20), whereas the 
Kinesiology Group maintained remission throughout the study (Figure 12). 
Table 25: Two-way ANOVA Illustrating Repeated Measures of Quiescent 
CDAI 
55 df MS I F P 
GROUP 9760.3877 2 4880.1939 0.45 0.63 
TREAT 37281.639 2 18640.82 7.59 0.00 
TREAT*GROUP 16357.522 4 4089.3805 1.66 0.16 
The result of the ANOVA statistic indicate that the mean COAl levels are 
significantly different across the stage of treatment (F=7.59; p<0.001), which 
could be due to a regression to the mean artifact, while the mean COAl is the 
same between the three groups. There is also no significant interaction between 















4.2.3 Patients with COAl 150-200 (n=15) 
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Figure 13: Patients with COAl 150-200 within the three groups at entry, 
post-treatment and follow-up. 
Table 26 illustrates the mean scores of patients with COAl 150-200 
Table 26: Mean Scores of Patients with COAl 150-200 
Entry Post-treatment Follow-up 
Control 177.03 ± 13.69 218.53 ± 64.70 189.63 ± 124.32 
Massage 179.65 ± 12.96 125.05 ± 90.18 148.03 ± 164.49 
Kinesiology 178.57 ± 8.47 194.00 ± 128.66 88.43 ± 16.10 











In patients with COAl 150-200, the mean COAl scores were similar in all three 
groups at entry (Kinesiology Group 178.57 ± 8.47; Massage 179.65 ± 12.96; and 
Controls 177.03 ± 13.69). Following four-months of intervention, and a three-
month follow-up, '!lean COAl scores were reduced in the Kinesiology Group 
(88.43 :I; 16.10) compared to mean COAl scores at entry (178.57 ± 8.47), 
reaching a level of remission (COAI<150). The Massage Group presented some 
change in mean COAl scores at follow-up level (148.03 ± 164.49) reaching the 
level of remission while the Control Group presented with some fluctuation in 
mean COAl scores but not sufficient to reach the stage of remission (Figure 13). 
Table 27: Two-way ANOVA Illustrating Repeated Measures of CDA1150-200 
SS df MS : F p 
GROUP 20235.525 2 10117.763 0.76 0.48 
TREAT 12173.85 2 6086.9251 0.96 0.39 
TREAT*GROUP 27891.906 4 6972.9765 1.10 0.37 
The mean COAl is the same over all three stages of treatment and in aI/ three 
treatment groups. There is also no interaction between the treatment group and 
the stage of treatment (Table 27). The small sample size might be the reason 
why the pattern of means is not Significantly different. 
Table 28: Disease Activity of Patients with CDA1150-200 at Post-treatment 
Stage 
Groups , N ~70 Points CDAI<150 CDAI>200 
Control 6 0(0%) 3 (50%) 3 (50%) 
Massage 6 2 (33%) 4 (66%) 1 (16%) 











At the four-month visit, the Control Group consisted of 6 patients, the Massage 
Group 6, and the Kinesiology Group had 3 patients with COAl 150-200. 1(33%) 
patient in the Kinesiology Group and 2(33%) patients in the Massage Group had 
a reduction of ;;:;:70 points in their COAl scores. Further assessment revealed that 
3 (100%) patients in the Kinesiology Group compared to 4 (66%) in the Massage 
Group, and 3(50%) in the Control Group went into clinical remission. 1(16%) 
patient in the Massage Group compared to 3(50%) of patients in the Control 
Group became active. In view of the small numbers involved, statistical analysis 
was not possible (Table 28). 
Table 29: Disease Activity of Patients with COAl 150-200 at Follow-up 
, Groups N ;;:;:70 Points CDAI<150 CDAI>200 
I Control 6 0(0%) 3 (50%) 2 (33%0 
Massage 6 2 (33%) 4 (66%) 2 (16%) 
Kinesiology 3 2 (66%) 3 (100%) 0(0%) 
At four-month follow-up, 2 (66%) patients in the Kinesiology Group and 2 (33%) 
in the Massage Group had a further;;:;: reduction in their COAl scores. 3(100%) 
patients in the Kinesiology Group compared to 4(66%) in the Massage Group 
and 3{50%) in the Control Group went into clinical remission while 1(16%) patient 
in the Massage Group compared to 2{33%) in the Control Group developed 
active disease. In view of the small numbers involved, statistical analysis was 
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Figure 14: Crohn's Disease Activity Index (COAl) vs. Erythrocyte 
Sedimentation Rate (ESR) at entry. 
There is a significant positive association between ESR and COAl at entry 











4.2.5 Correlations between ESR and COAl at Post-treatment 
·ESR vs.OOAlatPost.lreatment 
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Figure 15: Crohn's Disease Activity Index (COAl) vs. Erythrocyte 
Sedimentation Rate (ESR) at post-treatment level. 
There is a Significantly positive association between ESR and CDAI at post-











4.3 SHORT INFLAMMATORY BOWEL DISEASE 
QUESTIONNAIRE (SIBDQ) 
4.3.1 SIBDQ Scores of Patients with Active Crohn's Disease 
(n=87) 
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Figure 16: The SIBDQ scores of patients with active disease, within the 
three groups at entry, post-treatment, and follow-up. 
Table 30 illustrates the mean SIBOQ scores of patients with active disease at 
entry, post-treatment, and follow-up. 
Table·30: Mean SIBDQ Scores of Patients with Active Disease 
Entry Post-treatment Follow·up 
Control 36.71 ± 8.65 43.86 ± 12.19 39.57 ± 9.94 
Massage 43.36 ± 12.95 . 42.28 ± 13.04 40.92 ± 13.26 
Kinesiology 40.95 ± 13.02 46.21 ± 11 .96 48.39 ± 11 .51 











There was no significant difference in SIBOQ scores in patients with active 
disease at entry into the study. Following a four-month intervention period the 
Control Group, demonstrated an improvement in mean SIBOQ scores (43.86 ± 
12.19) compared t.o entry (36.71 ± 8.65). The mean SIBOQ score of the 
Massage_Group remained unchanged, while the Kinesiology Group als9 showed 
an improvement (46.21 ± 13.04) compared to entry (40.95 ± 13.02). At three-
month follow-up, the _SIBOQ score in the Control Group was reduced to a level 
similar to entry level, the Massage Group remained unchanged while the 
Kinesiology Group remained higher than the entry value (48.39 ± 11.51) (Figure 
16). 
Table 31: TwoMway ANOVA Illustrating Repeated Measures of 51BOQ in 
Active COAl 
55 df M5 F P 
GROUP 1115.0858 2 557.5429 1.67 0.19 
TREAT 524.78822 2 262.39411 4.81 0.009 
TREA T*GROUP 978.55728 4 244.63932 4.48 0.001 
The result of the ANOVA statistic indicates that the mean SIBOQ is the same 
between treatment groups (Table 31) while the mean SIBOQ levels are 
significantly different across the stage of treatment (F=4.81; p<0.01). The SIBOQ 
is strongly correlated with COAl (Entry r = -0.510; p=O.OOO. Post-treatment r = -
0.701; p=O.OOO. Follo"Y-up r = -0.684; p=O.OOO) and therefore regression to the 
mean can also explain this effect (i.e. an artifact). The interaction variable 
TREAT*GROUP indicates that at least one treatment type has caused a 











For more conclusive evidence, the TREAT*GROUP interaction is formally 
assessed for significance using Scheffe's test. 
Table 32: Scheffe's Test for Assessing TREAT"'GROUP Interaction 
Group Entry Post-treatment Follow-up 
Control 36.71 43.40 39.57 
Massage 43.36 42.28 40.92 
Kinesiology 40.94 46.21 48.39 '" 
*p<0.05 vs entry 
The mean SIBDQ level in the Kinesiology Group is significantly better at follow-












4.3.2 SIBDQ Scores of Patients with Quiescent Disease (n=48) 
. . .. .. .' . . ' ... 
Box PlotiUustratin SIBDQ $toi'esofQua&seent Patients . • ' . . . . :. ; . .... .. .. . :. :9 . ...... ; .. . . .... ;.. . . ' ..... . 
70 1---.. --===---==.,--------.. ----+---
60 
~ ...... -~~,----~--------------------------------
• , 'Yla:s.~a~ .• ::::; .. 
... ... ' ". . 
, ." . ... ..•. . . .. . :, " '.- GRoUP"· ' 0 
• _ •• __ · ' .. "0 
Entry Post-treatment Follow-up 
Figure 17: The SIBDQ scores of patients with quiescent disease, within the 
three groups, at entry, post-treatment, and follow-up. 
Table 33 illustrates the mean SIBOQ of patients with quiescent Crahn's disease. 
Table 33: Mean SIBDQ Scores of Patients with Quiescent Disease 
Entry Post-treatment Follow-up 
Control 54.04 ± 11.47 54.30 ± 12.52 47.56 ± 11. 18 
Massage 53.31 ± 11.47 50.31 ± 14.36 49.12 ± 12.73 
Kinesiology 52.78 ± 9.08 56.22 ±6.34 55.78 ± 11.22 











Patients with quiescent disease had similar SIBDQ scores at entry. Following a 
four-month intervention period, there were no significant differences between the 
groups. However, at three-month follow-up, the Control Group presented with a 
decrease in SIBDQ scores (47.56 ± 11.18) compared to entry (54.04 ± 11.47) 
indicating deterioration in quality of life. Whereas the result of the Kinesiology 
and the Massage Groups remained unchanged (Figure 17). 
Table 34: Two-way ANOVA Illustrating Repeated Measures of SIBDQ in 
Quiescent CDAI 
SS df MS F P 
GROUP 283.19917 2 141.59959 0.47 0.62 
TREAT 198.59141 2 95704 1.70 0.18 
TREAT*GROUP 413.76006 4 103.44002 1.77 0.14 
The results indicate that there are no significant differences between the stages 
of treatment nor the three treatment groups. There is also no interaction 












4.3.3 SISDQ Scores of Patients with CDA1150-200 (n=15) 
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Figure 18: The SIBOQ scores of patients with COAl 150-200, within the 
three groups, at entry, post-treatment, and follow-up. 
Table 35 illustrates the mean SIBOQ scores of patients with COAl 150-200 at 
entry, post-treatment, and fallaw-up. 
Table 35: Mean SIBOQ Scores of Patients with COAl 150-200 
Entry Post-treatment Follow-up 
Control 38.83 ± 7.08 40.33 ± 15.54 39.83 ± 16.24 
Massage 45.33 ± 11 .94 51.50 ± 15.06 43.67 ± 20.92 
II Kinesiology 35.67 ± 11.50 31 .33 ± 15.95 50.33 ± 9.81 











Patients with COAl 150-200 had similar SIBOQ scores at entry. Following a four-
month intervention, there were no significant differences between the groups. At 
three-month follow-up, there was a deterioration in mean SIBOQ scores of the 
Kinesiology Group (::>0.33 ± 9.81), while the mean SIBOQ scores of the Control 
and the M§lssage Group remained unchanged (Figure 18). 
Table 36: Two-way ANOVA Illustrating Repeated Measures of SIBDQ in 
COAl 150-200 
SS df MS F P 
GROUP 585.58889 2 292.79444 0.63 0.54 
TREAT 160.44444 2 80.222222 0.84 0.44 
TREAT*GROUP 745.37778 4 186.34444 1.97 0.13 
There are no significant differences between the stages of treatment nor the 
three treatment groups. There is also no interaction between the treatment 











4.3.4 Correlations between COAl and SIBOQ at Entry 
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Figure 19: Crohn's Disease Activity Index (COAl) vs. Short Inflammatory 
Bowel Disease Index (SIBDQ) at Entry. 
There is a significantly negative associ~tion between CDAI and SIBDQ at entry 











4.3.4 Correlation between COAl and SIBOQ at Post-treatment 
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Figure 20: Crohn's Disease Activity Index (COAl) vs. Short Inflammatory 
Bowel Disease Questionnaire (SIBDQ) at post-t~eatment. 
There is a significantly negative association between COAl and SIBOQ at post-











4.3.6 Correlations between COAl and SISOQ at Follow-up 
" " .... ;,': .:.. . 
CDAlvs.SIl:n:jQatf~now-u· ••.. 
.•..... ..~~~rlQ~~k491~.081~*ddAi .. 
, ',':,','. ,"::" : ... '" ':: '"'' ,';";'::, ,':'" ---:.:: - ":"',: " .... 
.... • Cor,jlatiprt:r==.~.684;p==O,Oo.Q: 
a 45 i-----tD-
Q 
.~. 35 ....... --
-. :. ,:. . . ," .. . .. 
·· .. ·~.··R~9re$$iQn 
t-=-~~=----:'--:-=-~--::2~50~.··.~·:~·"·"'::· ~~.........,-,"..,.-~~ $5%~(),rlfid; 
'" ... , ..... . 
" ., ..... . 
. .... " .. , 
CDAL .. 
Figure 21 = Crohn's Disease Activity Index (COAl) vs. Short Inflammatory 
~owel Disease Index (SIBDQ) at follow-up. 
There is a significantly negative association between COAl and SIBOQ at follow-











4.4 PROFILE OF MOOD STATES (POMS) 
4.4.1 POMS Scores of Patients with Active Crohn's Disease 
(n=87) 
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Figure 22: The POMS scores of patients with active disease, withir:- the 
three groups at entry, post-treatment, and follow-up. 
Table 37 illustrates the mean POMS score of patients with active Crahn's 
disease at entry, post-treatment, and fallow-up. 
Table 37: Mean POMS Scores of Patients with Active Disease 
Entry Post-treatment Follow-up 
Control 68.09 ± 18.17 68.33 ± 21.73 71 .33 ± 21.05 
I Massage 61 .96 ± 21.46 65.28 ± 26.98 67.28 ± 18.60 
Kinesiology 66.95 ± 21 .66 59.92 ± 20.62 56.87 ± 23.53 











Patients with active disease revealed no difference in mean POMS scores 
between groups at entry. Following a four month intervention period, the 
Kinesiology Group presented with an improvement in POMS scores (59.92 ± 
20.62) compared to entry (66.95 ± 21 .66), while scores in the Massage and the 
Control Gro~ps remained unchanged. At three-month follow-up the. Kine~iology 
Group presented with a further improvement in POMS scores (56.87 ± 23.53) 
compared to the level at .entry. The Massage Group presented with an increase 
in scores (67.28 ± 18.60) compared to entry (61.96 ± 21.46), indicating 
deterioration in psychological mood states. The Control Group also 
demonstrated an increase in POMS scores (71.33 ± 21.05) compared to entry 
(68.09 ± 18.17) (Figure 22). 
Table 43: Two-way ANOVA Illustrating Repeated Measures of POM5 in 
Active COAl 
55 df M5 F P 
GROUP 2137.0635 2 1068.5318 0.95 0.38 
TREAT 92.598023 2 46.299011 0.29 0.74 
TREA T*GROUP 2283.2041 4 570.80102 3.58 0.007 
The results of the ANOVA statistic indicate that the mean POMS levels are the 
same across the stage of treatment as well as the treatment groups (Table 43). 
The interaction variable indicates that at least one treatment type has caused a 
significant change in POMS levels (F=3.58; p<0.01). The significant result 
obtained in the ANOVA statistic requires that post hoc tests be conducted on the 
data. 
Table 39: 5cheffe's Test for Assessing TREAT*GROUP interaction 
Group Entry Post-treatment Follow-up 
Control 68.09 68.33 71.33 
Massage 61 .96 65.28 67.28 
Kinesiology 66.95 59.92 56.87 











4.4.2 POMS Scores of Patients with Quiescent Crohn's Disease 
(n=48) 
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Figure 23: The POMS scores of patients with quiescent disease, within the 
three groups at entry, post-treatment, and follow-up. 
Table 40 illustrates the mean POMS scores of patients with quiescent Grahn's 
disease at entry, post-treatment, and follow-up. 
Table 40: Mean POMS Scores of Patients with Quiescent Disease 
Entry Post-treatment Follow-up 
Control 51 .17±23.56 50.56 ± 21 .82 57.26 ± 20.44 
Massage 50.31 ± 18.90 55.69 ± 26.99 51.93 ± 20.83 
Kinesiology 45.22 ± 9.85 45.77 ± 8.01 48.55 ± 21.08 











In patients with quiescent disease, there were no significant difference in POMS 
results between the groups after four-months of intervention and neither at three-
month follow-up (Figure 23). 
Table 41: Two-way ANOVA Illustrating Repeated Measures of POM5 in 
Quiescent COAl 
5S df M5 F P 
GROUP 884.2800 2 442.14005 2.14 0.47 
TREAT 281.1104 2 140.55522 0.55 0.73 
TREAT*GROUP 524.891 4 131.22278 1.22 0.68 
The mean POMS levels are the same across the stage of treatment as well as 
the treatment groups. There is also no difference between the interaction variable 
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Figure 24: The POMS scores of patients with COAl 150-200, within the three 
groups at entry, post-treatment, and follow-up. 
Table 42 illustrates the mean POMS scores of patients with COAl 150-200 at 
entry, post-treatment, and follow-up. 
Table 42: Mean POMS Scores of Patients with COAl 150-200 
Entry Post-treatment Follow-up 
Control 84.33 ± 24.17 73.83 ± 17.86 68.67 ± 29.80 
Massage 67.17 ± 22.73 57.17 ± 27.66 65.33 ± 35.75 
Kinesiology 65.00 ± 12.16 68.00 ± 14.52 59.33 ± 15.37 











Although there were no significant results in POMS scores of patients with COAl 
150-200, the Control Group had a gradual reduction from 84.33 ± 24.17 at entry 
to 68.67 ± 29.80 at follow-up, the Massage Group from 67.17 ± 22.73 at entry to 
65.33 ± 35.7 at follow-up, and the Kinesiology Group from 65.00 ± 12.16 at entry 
to 59.33 ± 15.37 at follow-up (Figure 24). 
Table 43: Two-way ANOVA Illustrating Repeated Measures of POMS in 
COAl 150-200 
SS df MS F P 
GROUP 1584.0333 2 792.01667 0.62 0.55 
TREAT 437.52778 2 218.76389 0.68 0.51 
TREAT"'GROUP 600.13333 4 150.03333 0.46 0.75 
The mean POMS levels are the same across the stage of treatment as well as 
the treatment groups. There is also no difference between the interaction variable 











4.4.4 Correlations between COAl and POMS at Entry into Study 
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Figure 25: Crohn's Disease Activity Index (COAl) vs. Profile Of Mood States 
(POMS) at entry. 
There is a significantly positive association between COAl and POMS at entry 
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Figure 2: Crohn's Disease Activity Index (COAl) vs. Profile Of Mood States 
(POMS) at post-treatment. 
There is a significantly positive association between COAl and POMS at post-
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Figure 27: Crohn's Disease Activity Index (COAl) vs. Profile Of Mood 
States (POMS) at follow-up. 
There is a significantly positive association between COAl and POMS at follow-











4.5 Active Disease 'Relapses During the Course of the year 
The trial period commenced in February and ended in November, 2001. During 
February, patients were recruited for the study and commencement of therapy 
occurred in March and ended in June. The three-month follow-up evaluation was 
conducted in October. During November, the Control Group received a massage 
for being part of the study. During the period February-November, forty four 
percent of the sample had experienced one or more relapses, as determined by 
the attending physician. Table 43 illustrates the distribution of relapses between 
the groups during the trial period. 
Table 44: Relapse Rates During the Course of the Year 
Group Patients with relapses % of group 
Control 29 58.00% 
Massage 27 54.00% 
Kinesiology 10 20.00% 
• All Groups 66 44.00% 
There was a significant difference in the number of relapse rates between the 














Table 44 illustrates the actual number of relapses experienced by the groups 
during the course of the year. 84 patients had no relapses, 54 had 1 relapse, 11 
had 2 relapses and 1 patient had 3 relapses. 
Table 45: Breakdown of Groups by Actual Number of Relapses During the 
Course of the Year 
Groups 0 1 2 3 
Control (%) 21 (42%) 22 (44%) 6 (12%) 1 (2%) 
Massage (%) I 23 (46%) 22 (44%) 5 (10%) o (O%) 
Kinesiology (%) 40 (80%) 10 (20%) 0(0%) 0(0%) 
Totals 84 54 11 1 
Significantly more patients in the Kinesiology Group remained in remission (X2(6) 













5.1 Patient Characteristics 
At entry into the study the three groups, Kinesiology, Massage and Controls were 
of similar ages and there was no significant difference in sex distribution, 
although the majority of the groups were female. It has been reported that the 
incidence of Crohn's disease may be higher in women, by as much as 30% 
(Stenson et al. , 1991). The present study therefore confirms this finding. At 
entry the Control Group consisted of 28% males and 72% females in comparison 
to a Control Group with 26% males and 74% females and a Kinesiology Group 
with 30% males and 70% females. 
Using the BMI index, the majority of patients were found to be of normal weight, , 
with 31 % either obese or overweight and only 10% were underweight. It should 
be noted, that obesity affects the calculation of the COAl, and may lead to 
underestimation of disease activity. However, the mean BMI levels were similar 
between the groups. Patients were also similar on all haematological and 
biochemical values and were therefore equivalent for study purposes. 
The distribution of disease in this study population was also similar to that 
reported in the literature with 14% having only ileitis, 67% ileocolitis and 19% 
colitis only (SAGES, 1995). There was no significant difference in duration of 
disease between groups. Prior to the study, most patients had undergone one or 
more disease related surgical procedures. The Control Group had 66%, 
Massage Group 64%, and the Kinesiology Group 58% of surgical procedures. 












Fifty percent of the patients in the study had experienced an active episode of 
Crorln's disease in the year preceding the study. There were no significant 
differences in relapse rates between groups. Previous studies have indicated 
that approximately 70% of patients with Crohn's disease, who have had an active 
episode within the previous year, would experience a relapse within 6 months 
(Stenson, 1991). This study commenced in February 2001 and ended November 
of the same year. During this period, there was a significant reduction in disease 
relapse rates within the Kinesiology Group. 20% of patients experienced a 
relapse compared to 58% in the previous year. This relapse rate was also 
significantly lower in the same patients at follow-up and also lower than the other 
two groups. 
Despite random allocation of patients to treatment or control groups, there were 
more patients in the Kinesiology Group with active disease. At the time of 
interview, patients' disease activity was assessed using the COAl. 42% of 
patients in the Control Group, 56% in the Massage Group and 76% in the 
Kinesiology Group presented with active disease. 46% of patients in the Control 
Group, 32% in the Massage Group and 18% in the Kinesiology Group were in 
remission. Although there were significantly more active patients in the 
Kinesiology Group, mean COAl scores were similar between groups and the 
groups were therefore considered comparable for study purposes. The Control 
Group had a mean score of 177.03, The Massage Group 179.65, and the 
Kinesiology Group 178.57. Since the COAl is a relatively subjective measure, the 
ESR, which is an inflammatory marker, was also used as an objective evaluation 
of the patient's disease state. The significant correlation between COAl and ESR 
confirmed that the COAl was an effective measure of disease activity and the 
differences measured during the study were valid. This assessment revealed no 
significant differences between the groups at entry. The three groups were 











During the course of the study, patients continued to attend their regular clinical 
visits, and received regular Medical therapy. Use of steroids and 
immunosuppressives during this period was similar in the three groups, indicating 
that clinical differences between the groups were likely to be a result of the study 
procedures. 
5.2 Treatment Results 
The results of this study demonstrate a Significant association between reduction 
of Crohn's disease, improved quality of life, maintenance of remission and 
Kinesiology_ 
In order to determine the effect of Kinesiology on managing disease activity, and 
also in maintaining remission, at entry into the study patients were stratified into 
those with an active disease (COAl >200) and those with quiescent disease 
(COAl <1S0). The patients with an indeterminate COAl level of 150-200 were 
also assessed as a separate group. This division into strata however, had its 
disadvantages. The initial 3 groups of 50 (n=1S0) have been divided into 9 
smaller groups, with the active patients forming the largest group (n=87: 
Kinesiology 38; Massage 28; Control 21) followed by quiescent patients (n=48: 
Kinesiology 9; Massage 16; Control 23) and the indeterminate patients which 
comprised the smallest group (n=1S: Kinesiology 3; Massage 6; Control 6). In 
experimental terms it is much better to have a larger number in order to maintain 
power. In this study it was evident that due to insufficient numbers in the 
quiescent and indeterminate groups, results did not show significance, however, 
the pattern of improvement in the Kinesiology Group remained consistent 
throughout. 
Following the four-month intervention period, the COAl, a standardized clinical 











patient at a particular time, was used. The CDAI gives considerable weight to 
items 1-3 which rely on subjective assessment by the patient (Best et aI., 1976). 
The index may therefore be affected by the patient's personality and/or specific 
disease state. In a study by Teixeira and Ferguson (1979), it was found that 
some stoic patients had low scores despite the presence of almost complete 
intestinal obstruction or multiple fistulae. The opposite was also true. Patients 
with psychological problems had elevated scores despite an inactive disease. 
These researchers also note that patients with evidence of severe disease, and 
who are under control from medical therapy, may also show low COAl values. 
Therefore in this study the ESR, an objective disease marker, was used in 
conjunction with the CDAI to assess the patient's disease activity. In accordance 
with recent studies in Crohn's disease activity (Targan et aI., 1997), a change of 
at least 70 pOints on the COAl was considered to represent a clinical response 
and a decrease to <150 clinical remission. Tile SIBDQ was used for assessing 
quality of life and the POMS to evaluate the patient's psychological state. 
5.2.1 Disease Activity (COAl) 
After the four-month intervention, the disease rate in the active Kinesiology 
Group (COAI>200) had fallen significantly from baseline (p<0.001), indicating an 
improvement in disease activity, whereas the Massage and Control Groups did 
not show any significant improvement in disease state. Significantly more 
patients receiving Kinesiology achieved clinical response (66%) than those 
receiving Massage (32%) and Controls (19%). Achievement of remission was 
also greater in the Kinesiology Group (50%) than in the Massage (25%) and 
Controls (14%). 
At three-month follow-up there was a progressive overall improvement in disease 
condition of the active Kinesiology Group, but not in the Massage and Control 
Groups. Significantly more patients in the Kinesiology Group achieved clinical 











50% of the patients in the Kinesiology Group, 32% in the Massage and 9% in the 
Control group, achieved clinical remission. The ESR levels in the active 
Kinesiology Group remained significantly positively, although weakly associated 
with COAl (r=0.230; p<0.01), indicating that an improvement in disease activity 
was associated with improvement in ESR levels. 
The group receiving Kinesiology, who was quiescent (COAI<150) at entry into the 
study, maintained their remission throughout the study, whereas the Control 
Group presented with deterioration in disease state The Massage Group showed 
an increase in COAl scores but still remained within the quiescent state. At 
three-month follow-up, the Kinesiology Group maintained remission compared to 
entry and post-treatment levels. The Control and Massage Groups showed 
increases in disease state to the extent that the Control Group fell within the level 
of COAl 150-200 and were no longer in remission. 
Patients with COAl 150-200 in the Kinesiology Group as well as the Control 
Group demonstrated an increase in disease activiy while the Massage Group 
presented with a decrease. The ESR revealed no significant differences at this 
stage. At follow-up the Kinesiology Group demonstrated an improvement 
compared to entry and post-treatment levels and were in remission. The Control 
and Massage Groups presented with increases in their disease state but not 
sufficient to be of significance. It should be noted that the numbers were small 
and that the changes would not prove significance. 
5.2.2 Quality of Life (SIBDQ) 
Assessment of quality of life in patients who had active Crohn's disease at entry 
into the study demonstrated improvement in both the Control Group and the 
Kinesiology Group following therapy, whereas that of the Massage Group was 
unchanged. The improvement in the Control Group is somewhat surprising 











somewhat subjective measure (Irvine et aI., 1994), and the attention received 
during the course of the study may have influenced this improvement or it could 
be the case of regression to the mean. After 1he follow-up period, the 
improvement in quality of life in the Kinesiology group was significantly 
maintained, whereas the Control and Massage Groups presented with a 
decrease in quality of life. The Control Group decreased back to the levels 
obtained at entry into the study. 
The quiescent patients in the Kinesiology Group had an increase in SIBOQ 
scores, but not sufficient to be of significance, compared to the Control and 
Massage Groups who remained unchanged. At follow-up, patients in the 
Kinesiology Group remained unchanged compared to post-treatment level while 
the Massage and Control Groups presented with a decrease in quality of life 
compared to post-treatment levels. 
Patients with COAl 150-200 in the Kinesiology Group presented with a decrease 
in quality of life compared to the Control and Massage Groups who showed , 
improvement. However, these improvements were not significant. At follow-up, 
the Kinesiology Group demonstrated a significant improvement in quality of life 
compared to post-treatment level while the Control and Massage Groups 
showed a non-significant decrease compared to post-treatment level. 
Correlations of SIBOQ with COAl at post-treatment (r= -0.701; p<0.001) and 
follow-up (r= -0.684; p<0.001) is much larger than the correlations between COAl 
and ESR The strong negative correlations between SIBOQ and COAl indicate 
that a decrease in COAl is associated with an increase in SIBOQ implying that 











5.2.3 Psychological Presentation (POMS) 
Patients with active disease in the Kinesiology Group presented with an 
improvement in psychological states compared to the Control and Massage 
Groups who remained unchanged. At follow-up active patients in the Kinesiology 
Group maintained improvement in Mood states compared to post-treatment level 
while the Control and the Massage Groups presented with decrease in Mood 
states. These results were not significant. 
Quiescent patients in the Kinesiology Group maintained their Mood state 
compared to the Control Group who showed a slight decrease and the Massage 
Group who showed an increase in Mood states. None of these results were 
significant. At follow-up quiescent patients in the Kinesiology Group showed a 
non-significant decrease in Mood states compared to the Massage Group who 
had an increase and the Control Group who presented with an increase in POMS 
scores, implying a decrease in Mood states. 
Patients with COAl 150-200 in the Kinesiology Group presented with an increase 
in Mood states compared to the Control and Massage Groups who presented 
with a decrease in Mood states. None of these results were significant. At 
follow-up the Kinesiology, Massage and Control Groups presented with a 
decrease in POMS scores compared to entry level, implying an improvement in 
Mood states. However, these results were not significant. 
In this study Kinesiology was significantly associated with decreased disease 
activity with significantly more patients achieving a clinical response and 
remission. Kinesiology was also associated with improvement in quality of life. 
Correlations between SIBOQ and COAl at post-treatment (r=0.479; p<0.001) and 
follow-up (r=0.479; p<0.001) was much better than the correlation between COAl 
and ESR. In those patients with quiescent disease at entry, Kinesiology was also 











Recently, health-related quality of life has become a key consideration when 
evaluating different treatment options (Guyatt et aI., 1993). As stated previously, 
one earlier study ( Shaw et aI., 1987) showed that six three-hour sessions of 
Stress-release therapy was associated with significant improvement in mean 
Inflammatory Bowel Disease Index scores in patients with active Crohn's 
disease. In this study the SIBDQ, a disease-specific health-related quality of life 
questionnaire was used to assess quality of life. This is a validated questionnaire 
that has proven suitable for assessing the impact of disease and treatment on 
perceived well being, general health, and daily life function (Irvine et aI., 1994; 
Feagan et aI., 1994). The results of this study is consistent with that of Shaw et 
al. (1987). Kinesiology was associated with significant improvement in mean 
. SIBDQ in patients with active Grohn's disease. 
Although the SIBDQ consists of seven sub-scores, the total SIBDQ score was 
used to determine quality of life. The only disadvantage in using the total SIBDQ 
score is that improvement in overall quality of life can sometimes hide 
deterioration in particular aspects of psychological well being. Similarly, the 
, 
POMS consists of six sub-scores and although the Total Mood Disorder (TMD) 
score was used to evaluate the psychological state of this population, it would 
have been more beneficial to evaluate the various aspects of psychological well 
being of these patients. Specifically those patients with active disease. It should 
be noted that during and active disease state, patients receive additional or a 
change in medical therapy in an attempt to induce remission. This medication 
would therefore also affect disease activity, and quality of life, and steroids in 
particular may have psychological effects (SAGES, 1995). The use of these 
medications was however similar in the three groups and therefore, any 
differences detected between the groups is likely to represent the effects of the 











5.3 The Need for Adopting a Mind-Body Approach 
The positive result obtained from the intervention used in this research highlights 
the importance of physical contact with patients and the need for stress release 
interventions. This approach to physical and psychological stress reduction 
seems to have created a positive outcome for the majority of patients in the 
Kinesiology Group which also highlights the need to shift from a biomedical 
viewpoint, which only addresses the biological factors of disease, to a 
biopsychosocial approach, which can incorporate information about the patient 
as a whole including mind and body (Orossman, 1998). 
Both the COAl and ESR are disease markers which are used to assess the 
physical and biomedical aspects of disease (Best et aI., 1976). In other words, 
assessment of the body. Whereas the SIBOQ assesses both the physical (body) 
as well as the psychological (mind) aspects. The POMS however assesses 
purely psychological states, which can be viewed as the mind aspect (Mc Nair et 
aI., 1992). In this study the COAl shows the largest differences due, to treatment. 
The strong correlations between SIBOQ-COAI and moderate correlations 
between POMS-COAI compared to the weaker correlation between ESR-COAI, 
could be viewed as an indication of the need for adopting a mind-body approach. 
There is no doubt that the reductionist approach of biological medicine, which 
tries to reduce psychological notions to biological ones, has provided some truly 
remarkable technological advances and treatments (Watkins, 1997). However. 
there is also little doubt that the biological approach has certain limitations and its 
technological power must be balanced with the human qualities of care, 
compassion and empathy (Watkins, 1997). 
Adopting a mind-body approach would mean recognizing that illness is not 
merely malfunctioning of one organ or one bodily system, but a breakdown in a . 











spiritual. This approach would change the way a physician takes a history, 
examines a patient and ultimately manages their problem. It also allows for more 
creativity and scope to respond to the patient's dilemma of illness and minimizes 
the tendency to see individuals as biological subjects to be fitted into treatment 
protocols. Clearly no two illnesses are the same, and no two patients possess 
the same coping mechanisms and powers of recovery. Complementary 
therapies as an adjunct to conventional medical care, may have much to offer. 
Both Kinesiology and Massage therapy which were implemented in this study 
can be viewed . as Stress-release therapies. However, it is believed that 
Kinesiology provides a more intense form of physical as well as emotional stress 
release (Diamond, 1990). 
5.4 The Need for Stress-release Therapies 
Patients were very compliant. One hundred and fifty patients enrolled for this 
study and none of these patients withdrew during the course of the trial. This 
could be an indication that stress release therapies are welcomed by patients 
dealing with chronic illnesses. 
The latest psychoneuroimmunology research indicates that it is a person's 
perception of a stressor that is occurring in their life, and their response to that 
perception, which may influence their immuno-competence and therefore their 
health (Watkins, 1997; Kiecolt-Glasser et aI., 1995, 1993; Idler & Kasl, 1991). 
Psychoneurological research has also established a strong correlation between 
acute and chronic stress and coping skills in medical disorders and psychiatric 
states (Jiang et aL, 1996; Cohen et ai., 1997; Sutherland, 1991). Consequently, 
Blumenthal et al. (1997) and others (Fawzy et aI., 1995, 1993) have suggested 
that relaxation interventions as adjunct therapies could offer additional benefits to 
general health and improved quality of life. In light of the evidence from 











relaxation intervention offering physical and emotional stress reduction and 
additional benefits to general health, complementary to usual medical therapy. 
Patients often expressed their concern regarding the adverse effects of 
medication. Some acknowledged using complementary therapies to reduce their 
exposure to the side effects of conventional therapies and to try to find effective 
therapy for their disease. One patient reported that it gives her a greater sense 
of control in managing her health. Some patients expressed their urge to discuss 
the use of complementary therapies with their physician but are afraid of a 
negative reaction. 
The majority of patients expressed a major concern about having an operation. 
Other concerns were feelings of inadequacy, insecurity and the possibility of 
losing their job as a result of having to attend hospital or taking off from work as a 
result of acute abdominal pains or severe diarrhea. These findings confirm the 
notion that Crohn's disease patients have major worries and concerns about their 
disease (Dossman et a/., 1991). 
From the above findings it is obvious that patients have many concerns regarding 
their health. Many patients expressed their eagerness to attempt the use of 
complementary therapies but need some guidance to do so. Patients often 












Grohn's disease is often a chronic debilitating disease. The cost of the disease is 
high and patients may experience difficulty with permanent employment due to 
the unpredictable nature of their illness. The psychological distress of having to 
content with the concomitants of the disease was found to have an adverse 
effect on patient's health-related quality of life. Medical interventions generally 
focus on addressing the physical symptoms but not the complex psychological 
component of the disease. Grohn's disease patients were often disillusioned by 
the recurrent nature of their condition and side effects of medical interventions. 
Therefore, the need for efficient cost effective patient car~ and treatment, in order 
to keep patients in remission and out of hospital, have been expressed. 
In this study Kinesiology as an adjunct to medical therapy was shown to have a 
beneficial effect. Kinesiology was also associated with improved quality of life 
and reduction of the disease recurrence. These findings point to the necessity for 
treating the patient as a whole person which involves the physical, and 
psychological dimensions, and not just the symptom of diarrhea or abdominal 
pain. 
5.6 Implications for Clinical Practice 
From the results and observations made during the course of this investigation, 
several suggestions are offered which may be used by the attending physician to 
supplement the conventional medical care of patients with Grohn's disease: 
As noted earlier, participation in the study was in itself seen as a factor yielding a 
positive effect on patients. It seems reasonable to facilitate this effect in clinical 
practice by including patients' evaluation into the treatmE;lnt program. In a 











the physician, these actions would have the added effect of enlisting the patient's 
active participation in the treatment process. 
Findings that practicing stress management techniques decreases disease 
activity and was associated with improved physical and emotional functioning 
have direct implications for medical practice. These findings point to the 
necessity for approaching the patient as a whole system involving physical as 
well as psychological functioning. 
An understanding of the influence of stress and ways to manage stress may help 
patients adapt to and cope with their chronic disease. Stress management 
techniques could be a useful adjunct to the therapeutic regimen. They can be 
self-taught and serve to involve the patient in his/her own care. 
Physicians caring for patients with a chronic illness such as Crohn's disease, 
need to be aware of the therapeutic choices that are available in order to 
communicate knowledgeably with patients and provide optimal guidance 
regarding the choice of adjunct therapies. 
5.7 Recommendations 
It is believed that this study represents the first attempt at using Kinesiology on 
Crohn's disease patients in a research setting. Further studies using a longer 
time frame are needed to confirm the effectiveness of this therapeutic 
intervention. 
One of the four Kinesiology sessions was allocated to Emotional Stress Diffusion. 
In this research, Crohn's disease patients presented with very complex emotional 
issues. Further studies of this nature should consider allocating at least three 











Quality of life is a very important assessment for evaluating the effectiveness of 
any intervention. This study used a disease-specific health related quality of life 
questionnaire (SI80Q) and a psychological assessment (POMS). Although the 
total score of these tests were used, it would have been instructive to use the 
sub-scores of these tests, since the total score can sometimes hide deterioration 
in particular aspects of psychological well-being and therefore miss important 












Applied Kinesiology: a system of diagnosis and treatment that uses standard 
muscle testing procedures to evaluate body function, and applies a range of 
therapeutic techniques (Thie, 1996). 
Ch'i: Chinese term for vital energy. All matter, animate and inanimate is 
composed of and pervaded with this universal energy (Gallo, 2000). 
Distention: distention of the bowel occurs when some or all of the intestine 
balloons out from the presence of excessive amounts of gas or liquid (Sages, 
1995). 
Distress: an individual reaction to a perceived or real threat or stimulation. The 
purpose of distress is to enable the body to deal with an emergency situation 
(Selye, 1978). 
Defusion: a technique or energy release, which releases the emotions of fear, 
pain or fear of pain perceptions, associated with an event (Krebs, 1998). 
Fistula: an abnormal connection between two organs, such as between bowel 
and bowel, bowel and vagina, bowel and bladder, bowel and urethra, or bowel 
and skin. Two or more of these are known as fistulae; they commonly occur in 
patients with Crohn's disease (Sages, 1995). 
Ileostomy: An ileostomy is formed by the surgeon at the time of removal of a 
portion of the intestine in some patients with inflammatory bowel disease. The 
body's fluid wastes are emptied through the surgical prepared opening in the skin 
on the front of the abdomen, and the material collects into a bag which is 
attached to the skin by means of special adhesives. The bag is then periodically 











Indicator muscle change: (IMC) a muscle test that can be used to detect 
dysfunction of other body systems (Rolfes, 1996). Also see muscle monitoring or 
muscle testing. 
Kinesiology: Kinesiology uses muscles (see indicator muscle change above) to 
monitor stress and imbalance within the body and the human energy field. IMC 
is used as a diagnostic tool to detect and correct "energetic" imbalances in the 
body that may relate to stress, nutrition or injuries (Rolfes, 1996). 
Muscle monitoring or muscle testing: the impermanent loss of isometric 
muscle strength during manual muscle testing (Rolfes, 1996). 
Meridians: energy "gridlines" described and used in traditional Chinese 
Medicine. They are the channels or pathways that carry Ch'i through the body 
(Gallo, 2000). 
Regression to the mean: When selecting a sample from the lowest 10% of a 
population at pretest, most of them will probably be in the lowest 10% at posttest, 
but if even just a few are not, then their group's mean will have to be closer to the 
populations posttest than it was to the pretest. The same holds true for a sample 
on the highest 10% (Howell, 1997). 
Stress: Defined by Selye (1978) as the non-specific response of the body to any 
demand made on it. Stress is described by Pert (1997) as a condition in which 
the body-mind network is so taxed by unprocessed sensory input in the form of 
suppressed trauma or undigested emotions, that the body-mind network has 
become overloaded and cannot flow freely, sometimes even working against 
itself. 
Vital-energy: supraphysical energy that interpenetrates and vitalizes the 
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INFORMED CONSENT FORM 
This research is being conducted by Rasheda Jogee University of Cape 
Town, in partial fulfillment of the requirements of course PSY510W MA 
(Research) Psychology. 
The aim of this study is to evaluate the effect of a therapeutic intervention, which 
consists of massaging, on the symptoms of Grohn's Disease. 
In agreeing to participate in this research I understand the following: 
1. The research will involve 4 monthly sessions of 60minutes each. Participants 
will continue with their monthly scheduled appointments at Groote Schuur 
Hospital and these sessions will be used during the trial period. 
2. All data from the research will remain anonymous. Participants will be 
allocated a number which will be used, instead of their names, for the purpose of 
this study The data from all participants shall be compiled, analysed and 
submitted in a report to the course supervisor. 
3. The research involves no physical or psychological discomfort, harm or 
danger. 
4. Participants will agree voluntarily without coercion. 
5. Participants may withdraw from the research procedure at any time, without 
any penalty incurred on him/her. 
6. At the end of the research, participants will be given information concerning 
their performance and any questions they may have, about the research, will be 
clearly and fully answered. 
Researcher ________________ ~------------------
Research participant. __________________ _ 






















UNIVERSITY OF CAPE TO\VN 
21 November 2000 
REC REF: 22512000 
Ms R Jogee 
Psychology 
Dear Ms Jogee 
Research Ethics Committee 
Faculty of Medicine 
Anzio Road, Observatory, 7925 
Queries: Mandisa Tani 
Tel: (021) 406-6492 Fax: (021) 406-6390 
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Thank you for your application submitted to the Research Ethics Committee on the 08 
September 2000. 
I have pleasure in informing you that the Research Ethics Committee has formally 
approved the above study in November 2000. 
Included is a list of Research Ethics Committee Members who have formally approved 
your protocol. 
Please quote the above Reference number in all correspondence. 
Y ourss.qterely 
,(j kb().~ pwf 











    Signature removed 
Appendix 3 












Male I Female 
I Family status: Single on: Primary 
Married/Stable relationship Secondary i 
Widowed Tertiary 
Divorced/Seperated 
No of children: Dependent 
I Occu~atio.i: Not dependent 
CROHN'S DISEASE mSTORY 
Date ofDia Location ofCrohn's: Small Bowel 
Small Bowel & colon 
Duration of Crohn' s: yrs I Colon 
~~~L-~ ____ L-~______ ~ ________ ~ ________________ ~ 







I Have you had any surgery for the Crohn's? Type of Surgery: 
I Yes I No Total colectomy 
• Resection of small bowel 
! Resection of large bowel 
I Fistula repair 




























NAM E ............................... ., ............................... . 
FOLDER NUMBER ............................................ . 
Calculation of COAl REP 3 5 
Cays: 1 2 3 4 5 6 7 Sum Subtotal 
1. Number of liquid or 
very soft stools I _1_'_1_1_1_1-1 x 2 
2. Abdominal pain rating 
0= none 
1 = mild 
2 = moderate 
3 = severe I _1_1_1_1_1_1_ I x 5 
3. General well-being 
o = generally well 
1 = slightly under par 
2 = poor 
3 = very poor 











Check the box(es) for the specific items: 
o Arthritis I arthralgia 
o Iritis I uveitis 
o Erythema nodosum I pyoderma gangrenosum I aphthous stomatitis 
o Anal fissure, fistula, or abscess 
o Other fistula 
o Fever over 37.8°C (100°F) during past week 
Number of 6 listed categories patient now has: 
5. Use of diphenoxylate, loperamide or other 
opiates for diarrhea 
0= no 
1 = yes 
6. Abdominal mass 
0= none 
2 = questionable 
x 20 ___ _ 
x 30 ___ _ 
5 = definite x 10 ----
Males: 47 - Hct 
7. Haematocrit: % Females: 42 - Hct x 6 ___ -
Add or subtract according to sign 
8. Body weight: _ _ kg Standard weight: __ _ kg 
body weight 
(1 - ----------------------) x 1 00 = x 1 
standard weight Add or subtract according to sign 























Short Quality of Life in Inflammatory Bowel Disease Questionnaire (SfBDQ) 
This questionnaire is designed to find out how you have been feeling during 
the last 2 weeks. You will be asked about symptoms you have been having as a 
result of your inflammatory bowel disease the way you have been feeling in general, 
and how your mood has been. 
1. How often has the feeling of fatigue or of being tired and worn out been a problem 
for you during the last 2 weeks? Please indicate how often the feeling of fatigue or 
tiredness has been a problem for you during the last 2 weeks by picking one options 
from 
(Systemic) 
1 All of the time 
2 Most of the time 
3 A good bit of the time 
4 Some of the time 
5 A little of the time 
6 Hardly any of the time 
7 None of the time 
2. How often during the last 2 weeks have you had to delay or cancel a social 
~ngagement because of your bowel problem? Please choose an option ~rom 
(Social) 
1 All of the time 
2 Most of the time 
3 A good bit of the time 
4 Some of the time 
5 A little of the time 
6 Hardly any of the time 
7 None of the time 
3. How much difficulty have you had, as a result of your bowel problems, doing leisure 
or sports activities you would have liked to have done during the last 2 weeks? 
Please choose an option from 
(Social) . 
1 A great deal of difficulty, activities made impossible 
2 A lot of difficulty 
3 A fair bit of difficulty 
4 Some difficulty 
5 A little difficulty 
6 Hardly any difficulty 
7 No difficulty; the bowel problems did not limit sports or leisure activities 











4. How often during the last 2 weeks have you been troubled by pain in the abdomen? 
Please choose an option from 
(Bowel) 
1 All of the time 
2 Most of the time 
3 A good bit of the time 
4 Some of the time 
5 A little of the time 
6 Hardly any of the time 
7 None of the time 
5. How often during the last 2 weeks have you felt depressed or discouraged? 
Pleases choose an option from 
(Emotional) 
1 All of the time 
2 Most of the time 
3 A good bit of the ti me 
4 Some of the time 
5 A little of the time 
6 Hardly any of the time 
7 None of the time 
6. Overall, in the last 2 weeks, how much of a problem have you had with passing 
large amounts of gas? Please choose an option from 
(Bowel) 
1 A major problem 
2 A big problE;)m 
3 A significant problem 
4 Some trouble 
5 A little trouble 
6 Hardly any trouble 
7 No trouble 
7. Overall, inthe last 2 weeks, how much of a probelm have you had maintaining or 
getting to the weight you would like to be? Please choose an option from 
(Systemic) 
1 A major problem 
2 A big problem 
3 A significant problem 
4 Some trouble 
5 A little trouble 
6 Hardly any trouble 
7 No trouble 











8. How often during the last 2 weeks have you felt relaxed and free of tension? 
Please choose an option form 
(Emotional) 
1 None of the time 
2 A little of the time 
3 some of the time 
4 A good bit of the time 
5 Most of the time 
6 Almost all of the time 
7 All of the time 
9. How much of the time during the last 2 weeks have you been troubled by a feeling 
of having to go to the bathroom even though your bowels were empty? Please 
choose an option from 
(Bowel) 
1 All of the time 
2 Most of the time 
3 A good bit of the time 
4 Some of the time 
5 A little of the time 
6 Hardly any of the time 
7 None of the time 
10. H ow much of the time during the last 2 weeks have you felt angry as a result of your 
bowel problem? Please choose an option from 
(Emotional) 
1 All of the time 
2 Most of the time 
3 A good bit of the time 
4 Some of the time 
5 A little of the time 
6 Hardly any of the time 
7 None of the time 
Cl Copyright, McMaster University, Hamilton, Omario, Canada 
Any further use or copying of !his questionnaire must be aulhorized by a separate 
licensing agreement Please contact !he Office of Research Contracts & Intellectual 























NAME ______________________________ __ DATE ______________________ __ 
S EX: Male ® Female 0 Identification No. ____________ _ 
Below is a list of words that describe feelings people have. Please read each one carefully. Then fill in ONE circle 
underthe answer to the ri9htwhich best describes HOW YOU HAVE BEEN FEELING DURING THE PAST WEEK 
INCLUDING TODAY. . 
The numbers 
refer to these phrases. 
0= Not at all 
0= A little 
@ ::: Moderately 
o = Quite a bit 
o = Extremely 
~.-t= >- ~.-= >- ~.-= >-= _.oQj = _.oQj "iij 1;j.o(ji ~ e at E .~ e III E 
- II) .... III E III J!! aJ aJ II) at J!! aJ aJ aJ lII-aJaJaJ 
~~~8jj os"8~5~ 15 ,g "8 ·s -= z<::EOw z<::EoUl 
1. Tense ·00@00 12. Uneasy ·00000 23. Weary ·00000 
2. Angry '00@00 13. Fatigued ·00000 24. Bewildered '00@00 
3. Worn out 00000 14. Annoyed ·00000 25. Furious . '00@00 
4. Lively 00000 15. Discouraged ·00000 26. Efficient ·00000 
5. Confused 00000 16. NervolJs ·00000 27. Full of pep '00@00 
6. Shaky 00000 17. Lonely '00@00 28. Bad-tempered 00000 
7. Sad 00000 18. Muddled ·00000 29. Forgetful '00@00 
8. Active 00@00 19. Exhausted ·00000 30. Vigorous . ·00000 
9. Grouchy 00000 20. Anxious . ·00@00 
10. Energetic 00@00 21. Gloomy '®0@00 MAKE SURE 
YOll HAVE ANSWERED 
11. Unworthy 00@00 22. Sluggish '@0@00 
EVERY ITEM. 
~ POMS COPYRIGHTe 1989 EdiTS/Educational and Industrial Testing Service, San Diego, CA 92107. 
\QIJ!(' Reproduction of this fonn by any means strictly prohibited. 
5HORT FORM 
























Number of liquid or 







Generally wen =0 
Slightly under par =1 
! 
Poor =2 
Very poor =3 
Terrible =4 
I Record evening 
temperature if you 
: feel feverish? 
DC 0 oraF 0 
Loperamide, 
diphenoxylate I 
atropine- or codeine 
phosphate 
medication taken? 
YES or NO 
Monday's date CD ,--I ~I .1'---111 L..--2 .1...--1 °I...-...J----J 
Day Month Year 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
, 
• Also known as Lomoti!, Oi-Atro, Logen, Lonox, Reasec, Eldox, Olarphen. Tropergen. Protector, Co-phenotrope, Retardin. English 
Patient 
Initials 
Number of liquid or 







GeneraHy well =0 
Slightly under par =1 
Poor =2 
Very poor =3 
Terrible =4 
Record evening 
temperature if you 
feel feverish? 
DC 0 or of 0 
Loperamide, 
diphenoxylate I 
atropine- or codeine 
phosphate 
medication taken? 
YES or NO 
Monday's date CD 1..--1 -1...-.1...-11 1...--1 2 ...!.--l 0--L.....-.-I...--I 
Day Month Year 























Male I Female 
PHYSICAL SCREENING 
COMMENCEMENT.: FOLLOW-UP VISIT COMPLETION: 
! Date: Date: Date: 
Height: 
Weight: Weight: Weight: 
BMI: BMI: BMI: 
LABORATORYSCBEENING 
ON STUDY COMMENCEMENT: 







FOLLOW-UP DURING STUDY 







ON STUDY COMPLETION: 
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DEMOGRAPHICS - PASSIVE CONTROL GROUP 
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2001 Wt Bl!'i W! .. ; .... Brrli. _____ .. ~t ,Bmi_ 
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-- ---.~--- --~.- -.~-. --.~ ~__ c_~. _ .. _+-... __ 
o 62.2 24.3 63.21 24.7 68.8: 26.9 ,- -'-- - ~- ---'-- -+ ... _- .-... ,,- __ ."H ~ . .. H'~ __ 
o 73.5 30.6 69.5! 28.9 67: 27.9 .-- . • ___ ·_w. ----... __ .. ~ .... .),_ .. __ .__ _ ___ w....i "'_~ __ 
2 1 05 32.8 104.6 1 32.6 104.5' 32.6 • __ • .. -.- . - - ~ .. -.- •. -- - _, ___ .L.w. ___ _ _ __ ,,_~
.Q ___ ,, __ ~ ___ 51, __ ~Q} __ .~~L 20.2 .49 •. 19.~ 
1 64' 28.4 65: 28.9 65 28.9 ----... ~--- .. +-.--- -----t- . - -t,-~ 
o 45.5 19.4 43.71 18.7 43.5: 18.6 
. --... _- - ... - ... '----- ... - --~.-.-----.". 1-'·' ----- ...... ~ --_ 
.1_ 5?:§_. __ ?!.3. ~J-4--_~1.1~. __ y~.21._ 21.7 
! ___ 6S._.?3~ .. __ 64.§L ___ ?~._1 _ .... _ ... ~4;. __ 22.9 
1 66 24.2 65! 23.9 63.5: 23.3 ... -- ---. - .. ---.. -.-- - ------j-.. -.. -.--.-I--.--- -'i' 
-Q-- '§Q:~. -. ~?.3 ____ ... __ _y?~j_.1.3.1 _.§_5.:1L __ 2,4 
1 57 23-4. _._?S:~ i ~4.2 58; .?~B 
1 73 2S.2 62.5. 24.1 61.5' 23.7 
o 4!;)"'-" 20.4 -'- --4B:5~ 20.2 -. 4S' '20.2 
- ._.w_ .- ......... --~ ___ ",-1. _ " __ • I, . __ ~_ 
o 60.05 25.7 60 25.6 60 25.6 .. ' ... -. ....... .... ---·--·1···· .. ·-·· .---. ___ _ 
2 45.5 17.1 43.6 16.4 40.5 15.2 
. . - ,- .... -.--- _ .. -.... I. -.... --"'- 1 ___ . . .... __ 
1 58.5 22.7 59 22.9 57 22.1 
-6 61" 22.4' -57~5:'- 21.1 ,. 5620.6 
-- . -- .... ..., -. -- -'-1- _.-
3 61.5 23.7 62.5: 24.1 61.5 23.7 -.' ._._--- _ .. -" --- ---_ .. - ----~.-... - .. ". . .. _-
1 __ ~?.§_ ?.:4.7 _.§~~_.?~5 56.?" ~3.8 
2 72.5 27.3 73 i 27.5 75' 28.2 
.-. --.----. -'-."--.' .... ... ---'--i"'" ...... . +._. __ 
o 74.5 30.3 73.8! 29.8 73. 29.4 
1 ----63.523.6 62 -- 23.1 ... 58 '2f6 
.-.. ---.--.- ... --- . "-' l--- ... --._ ~_. . ...... _._ .... _. 
1 ~~_ 31:2 . __ . ._~~~_._31.2 ... _!39._5.i 31~ 
1 65 24.9 66.4 i 25.5 67.11 25.7 " .. -... ... -. -- ._- ~- .... ,.-.---.. --,---.. ... r---'--- .... -----o 65.5 20.S 73.4: 23.3 81. 25.7 
0--- --62' 23:6 ----- --·6ist ··-24.2 '--61"-- 23.2 
1-- .. -····- SO.5 27.2 --- -- 80" 27 79 -'26.7 
.. _._- --.. --- - .. .. - -- .. - - , .... - .. --- 1-' ....... r---'"'' j .. --, 
o 65.5 23.8 63, 22.9 61.5, 22.3 
.• -. • .. t . - -- .~-- -'-..... • .•. _. __ 
1 69 25 70 25.4 67 24.3 










'--'---~~:l~-'--' -]~f~.----_\ __ ~~1~~tl 
'. H~~--.. -. -~~1¥---i-- ~ ~~l ..· .. · 
···~--~~~~---·;~==t=1!~i 
.-14~!=-_--~~?1M.==j_-- ~.~o r 
J:~L_~! \ ~~~l· 
__ .~4~t ___ ~? £. I 1_~~1 
---1:it-- .. --~~* I--i~~ 1 
. ---I--·---L.- 1 ___ -, 
14!t--_h_~F i .1~1~_ 
.. ' ~:~+---~~t~----t--~~~! 
. 150\- -15 1F ! 164:-
DEMOGRAPHICS - PASSIVE CONTROL GROUP 
29' 
15, 
5 -==t=._·13 _ 
---- 13 
___ -I- 271 
13 
_ . ____ 10 
_ .... ~~ ===. ~.·=l. ~ ': 
.. ______ ..... 19' 
. _ _____ 14' 
._ _ ___ -13~ 
26' 
. ___ -1--_ 18 ' 
5 
OT 0 -'5+--'-- ... -6· 
~.~.- ,. 
U-- 1 
__ ~--- .. -2 
l 
1 .. _---, --'- _ .... 
o 0 
.- - - -----o 0 
--~ ----~-. 
-'--1r- ------. ___ ~___ ___ L 
o· 0 





. __ 6~:Ei_~6.6 . _ . n_ 64.51 26.2 . ___ ._ 63.2 L~~·6. 
79.7: 33 79.5! 32.9 78 1 32.3 -'-'--' .. -f·- .- .. --t-.----.- -_ ... ----.. - ---- f------. 
61.6, 25 61, 24.7 61 24.7 
--'43:5:---18.6-----431 18.4 ---- 43 18.4 
_~ ____ .c __ ..... _ _ __ ~____ • ___ _ 
.~ __ .__ 7lil_?9.~ ___ __73.6\. 28.7 ____ 73.6 28.7 
. .. _ .. ___ ~~~ ___ 28.~ . ___ 64l 28.1 ____ 62.6 2?..:~ 
___ ._J~?:§'~___ 21 . __ ._ 8~~_ 26.:.~ I' .. _ 84 25.9 
49' 20.1 47.5 i 19.5 47 19.3 
--- SF----195 - 51.31 19.8 51 19.7 
.- _=:---5~~j=.~~:! __ ._n __ ;~-~1~~t __ u ;~ ~~~1 
-----+ -.. .---. - --- ! :.J 
. ____ . __ 63 i_?4.~_____ _. __ ~2.51_~~~ _______ .__ 62.4 24.1 
60.05! 23.2 60.02! 23.2 60.05 23.2 
-~---.~-'-. "'- --'-' .-- - ---. i- ~-=------
86.4 ~ 30.6 83.5 I 29.6 83 29.4 • __ ..... ______ 1._.. _ .. _____ .1. ____ . __ . _____ '_" _______ ---'--. ___ 
55: 18.6 51 i 17.2 50 16.91 
._-_._---_._; _d' - __ - _______ + ____ -=-= , ___ . ______ . __ .___! -










DEMOGRAPHICS· ACTIVE CONTROL GROUP 
I --; i! RELAPSES COMM END OF INTV 3 MTH FlU 
SUIiNOr:::~·r::~~:T-iil-=1 DUFi-: 2000 ~ 2001 .... =~reml.~=_- '-'ViI!.;a~iVl't_ 1 ami 
--?~1t~-_-?5jF L __ 1§~~.__ 7'?~_ __ 1 ' ".__ 60.05i _??3.,._,_ ,.§Q., .,22.3 __ ', ____ §9~?3 
--~!!t=~~~~~==-:=t- !t----;i:l= .. ~. ~i:itii- ~ :=~~t={g ~ ~~!ill ~g 
,-·)~~r=~~,.4~l~=-~=_.L~-1~T5·L ... _ ___ ,19: , TI~ '1 __ . __ .§{?3.§. '~.'" 5.4 ~ ._~,,?~] ___ 1"- .~4t-J.~~ 
207
1 
47!F i 1531 16 1: 1 91.5' 39.1 98~ 41.9 97.31 41.6 --.-,-._ .. L __ .""" . .J _____ --,-- ______ •• -'-- .. -.- .••••. ,,+----., , L - •. ---- .-,.' ... ,-,'"'' ".-.... ,t----;,'-' 
.""_,~~~J--'''--:;j~ --=l~-=J~Jt. ~== -"~~.~~lt.= ~ _Jt ,.~;~~ ==-_ ==·~5tJ.._~526 _ ... ~f~t;6:; 
210: 471M ; 168: 17 0 1 0 80: 28.3 78.51 27.8 80.21 28.4 .... ---..... L.-, ..... "L---,--·l"---·-·--.. · ',-+ ' . _. ____ , L ." ___ ,_,_ .. 1.._ ,,--. '" .-"--t-- _ ,_ 
'--211L-.,,~L~,_ .. _+ __ !65; 28 ___ .9.L 1, __ .___ ....11: .. ,2€3:.1 __ ,?.1:.5.J ___ 26.3 ,,!:1:?L. 26.3 
2121 48!F i 153i 17 01 0 76, 32.5 74; 31.6 72.31 30.9 ----,,--.,,_"'::.l--_ ... __ ,_~ . . --'-.+-----. ... "'-"'-i- -T"" , -_ ..... _ ,t-.-. , __ ." .. L __ 
.--.-.~1~~---~n~---l--!6.!l ' 9 _Q.L __ . _ 1 ... _____ ,~O.;- .1~:~--... .§?l.,,,.1Q.J __ 5~~UO.3 
---"~~:t----,,-·~f~ ! 1513s:t· .. --- 1: __ ~i -... .~ :~~~'''1~~~ -, --... ~~: ... ~~:~. __ S.79~t ~:~~ 
.. ,' --+---. -'~' '-'''-''1 -----'; ... ; T'-' , , ------ .... ,J, • " __ ._.. . + ___ _ 
216 1 39F I 169] 13 2, 1 57.4 20.1 58 20.3 57.4; 20.1 " "--j---'---"-' -- _J_, __ ~ ___ ._. _____ --._-!-. . --... ;:;t- "~ .. - - __ .... ...1.. • ___ • _ •. _ •• _~,."_ .< .• ___ + __ ~~~_ 
217 33'F ,157: 15 0, 0 116' 47.1 114. 46.2 112.5! 45.6 
218' 59~F-'''--'':-''-'-160! 5 ""or 0 55.3 21.6 52: '20.3 53r-20:i 
. , .• -. l_ .--- ._--, _ .... _ .. 1 . _1.. .._ ... ~_ ... " • .._ _+ ._.,._~ _____ ,_,_ *_~ 
219: 61!F i 170! 13 0 a 79.5 27.5 80· 27.7 82' 28.4 .. _._._- .. "~_ . .1..---___ . - .. ~. -".~--:------.-~.-~ "j-. •• ,, __ ,-L-_ - •. __ .. _. __ _~ ___ "'., ___ ~_,. _______ ~ __ ~~" ". "".~ .. , l_~ __ _ 
220i 381F : 168 1 14 0: 0 46: 16.3 47.6 16.9 46! 16.3 .... ,-..----", .. -,. r",--",,+-.,. ____ ,____. --- __ . __ .... _ .. "._, __ ....... _.. ._ C''' '" .. ,;;i----
221: 38:F.,' 164; 11 1 62.5 23.2 67 24.9 671 24.9 222: ··S5:F'----' 16ft 12 1 1"52 20.154' 20j~I'--'''-' 55.9!-'2:1:6 ",,----,- ---r----.-."'---- .... ---,J... '--, ---,. - .. - _-1-._" -- _ -- ---,---, ". _ . _____ , .• ___ . __ 1---"" _...1...-...:_ 
~:.==.~~~L_=~3;1~-____ J. __ ·~~13s~L. __ .. ~~.~1 ~.- .. ~f;~: ~~:t ~Ll~::·7£l~4 
2251 311F 1 1691 5, 0, 1 70, 24.5 73: 25.6 72.51 25.4 '---,4·----' .. -·-f·----~, .. --·---___ i".. ", .. ---.-1----- . _ ---_ ._,' ____ _ ___ , .... _"" 1"--.---
226; 221M : 175 1 6 01 0 65 21.2 65· 21.2 64: 20.9 ' . L __ . ____ ' __ ; •. ,, ____ , .. _., __ , __ ,,_, .. .,... ,,,,. -" ,. _'_""1--'_ C' .... --,--+--.--
227 331M " 148:. 7 01 1 58.5' 26.7 58: 26.1 57.5' 26.3 ·,------·--'c'-,·-------,,·i "'---. --4." _ __ "'" , ... _ .. __ " "" •• ,_,,_._ .. __ • __ , _____ ~ __ -__ ,--.-
228 391F i 164: 18 2 2 60.05 22.3 64.2 23.9 67.5; 25.1 
229, 29tM-·· .. ~r .. · '-'169[- "14' -- 1: 0---85: 29.8 -"----8~t "2!f4 --- ---'8~ft-i9-:-4 
-.-230~·----52TM---·+--178i-'-15:-(n 1-.. ,. -----75: 23.5 '7'(-'24.2 .. '76:51---- 24 
-- '- -4.----".--.-'-r.-.----~"-.--- .. ''' .. -, .. __ . , -- ,,----.----- "---"- ----,,--- _._ "", ... __ .. -i-::-'-:::' . _____ , ____ .~-"'-
231: 20 M : 166' 5 0: 0 68.3 24.8 68.5 24.9 63! 22.9 
-, 2321-----' 50W-----· _L_. 15f-l· , 5-'-1'1' -, 2 ' .,-- - ·74.8·3:fa" --·-73'--- 32--'j1t---3r'1-
'''._, , .. ,.,--,,-... _,-+--- --_____ ._1. '... ",L.. .. '" ___ " .. __ ....... "'. __ ,_. ___ ,,"'_ '"_",, ~__ __+~ ___ . __ 










DEMOGRAPHICS - ACTIVE CONTROL GROUP 
I---{!k ~ij~: 15~~t ! 
--- .j.-- . --- -- i---
238: 18iF 154, 0 
~--::-:-- _L____ . --1---- -- ---i--- --- ----- -_ .. 
__ ~_9! .. __ _?9l 15~L __ l' 
,--_24_0_1 ____ ~F 15~tH 1 
_____ ~4 ~ j2~ l F.. ___ ~.----1 ?_1_ ,3 
,---~~~~----~~t~ ~~~- --- -1~: -----~-
-----244t--421M 18It- -----·---17'---- o· 
- 2~~1~_ ... '.' -~~lF 156.5L~~-_-. ~~-=_ .=:~Qt= _____ : -1'~ 
----~~;1-·· '~+f~ ~:~l-·- . 1~1·__ ~ 
~---248t-· 5:fIF-----r-- 167t·---- 8! 0 _______ .+ .... _ .... i._. __ __________ •.• _ ..... _ _ .... I 
249! 50lF 1621 6: 1 
'---i50;--3iiF '169'-' 1. 
o 51_5~. 18.9 49:?\ 18.2 __ 49.5~.2 
~ ______ . ~:_ ... 273~ _... ::~t-i~:~ --.. -87:iF~:; 
1 .57.4 24.2 __ . _. 55.?L_~ _____ . _ .... _56 23.6 
J -------- 527~' .~ ~~i -- ;-H ==--. --·--J5.?6~ ;~:: 
o 116.5 39.8 107 36.6 106.5 36.3 
~-~ ~~.~.;~; ~~~E;~:; ---.. _~·.-_]l~-"-~~ 
o 58.4 18.1 57.7: 17.8 57.5 17.7 
'1 61.5 .. 25.1~) i 24.9_ ·-=S9:.§ _ 24.3 
63.9 22.6 651 23 68 24.1 .... --. .. · .. -1----- .---- --.-. 
~. . . 65 11.:.1 __ .. . 64'~i_ 26.8 __ .__ ____ ~4 .... 26.61 
o 79.7 28.6 79.5, 28.5 78 28 -- ·-t----...... --- ---- -
1 78.5 29.9 75, 28.6 73.2 27.9 










DEMOGRAPHICS - EXPERIMENTAL GROUP 
1 RELAPSES . COMM END OF INTV .. 3 MTH FlU 
~~]~ j,~~~ ~ Sex I --H1;r--~DUR1f~~0-~~~i -.• 2001
1 
--. -::~f-~~:~-~= ~=;~ B~~ == ~H~'~ 
303 - 42 F 163 --- 101----01-- 0 187- 44.4---- ---119 44.8 128 48.2 
- ----- -- -!.-----.~ . ------- 4 __________ ,._______ __ __, .. ____ ,, __ 
1 ________ 
3 __ 04 59 F 163 14~ _______ ~ __ 1 63:_~ 23_:§} _______ 64.4 24.2 58 21.8 
3!l~L _______ ~6 M 188 21: ----1i 0 _____ 75~ __ ~J.2_ _. __ ,,_]6~~,-_~1:~ __ 77r--?1:~ 
306i 66 F 157 19i 01 0 78.5. 31.8 79 32 80 32.5 ,-----1----- _ ,-----,---,----L __ _ _ ____________ +. ___ ,,__ __ ~_ . ______ _ 
E
- 3~!+--- - 45 F 153__ 18; __ 3 i_ 0 ~3;_ 26.9 _____ _ ___ . _,, ___ .64.6 27.§ __ 67 28:~ 
-=~~T::::'- :~ ~ 1~~~ =-~H==*: ~ ==:- ·-;~;it ~~~ --.~ :=- iH.~ c- 5~~ -g:! 
-- 31ft----- 42 M 163- 1- - 281-2-1' 6 --54~2o~3 -- ------4'gf---fa:4 47 17-:-7 
---312----- 65 F 171'- 1-· --12 i ---7--- 6 -71:2:-- 24~3 ----- .- f- 70.5 24.1 72 24:6 -------~----.-,--- ---- --- -, J -----~-- -_______ ,,___ _J..________ _, _____ _ , _____ , 
__3~~ _ 55 F J133 _____ ___ 11 :-------Ql--- _Q 7~J._ 27:~ _______ ____ 78 29.4 74.6 __ 28~1 
314i 36 M 165 12 0; 0 54: 19.8 55.5 20.4 56 20.6 
1--- 315 ]- 31M ---168 - .. --, - - 6 ----"21 - 1 56.5:------20 -- - --, - 58 20.5 60.4 [----=--:-.4 
3161 43 F ---"+15'5.S f ------ 15: - 61 0 --SO.3 i 24.9 - 'SOf---Z4.8 ---"- - 60.St--- 25 - -.- --+-..... ------=-- ---1--.---- 1----- I -----------t'- ______ _ ___ +________ . _. ____ _,_. 
317L~?F 15~,:? ____ , __ , 14: _Qj 0 J1.11_~7.9 -,.!~.~f__---?!!:~-----.,---- 76.6 ___ ~Q:1 
318; 39F 158 14: 11 0 40: 16 40.5 16.2 41 16.4 
319;-- 44 F ---157 1 14: -'--or 0 -.- -s2.4-:---2-1.3 -, 53.6 21.7 54 21.9 
--· .. ---- .. f-----.. - .... - I -" ----!---- .--- --+----- t----_.-
320 1___ 33 M _ 161 ,__ 12 __ ~ 9 ._ ~:~,j-~1,.1 56.6 21.8 57.5 22~ 
321' 45 M 167 26' 1; 0 76.2: 27.3 83' 27.5 92 27.5 ' t-.. ··,,,----- 1---- '---- --~ - -______ .. .1 --" , • ____ + ______ 1_,__ ... , 
322 54 M 180.5 5_ 1! 0 74 22.7 75 23 75.3 23.1 ---.-----j--,,- ------,- -+----1-- ~ --,~ -~l,----.. ---1,,,-- - 1---, _",, __ 
~~~L_~ __ . 18 M 165 7" 9 _~9:~L .. J§:_? __ 51 18.7 ,__ 52.3 19.2 
324! 46 M ! 146 21, 0 61; 28.6 59 27.7 59 27.7 
=~~ 3~5L,__ 61 F 1§Q+ ___ __ .. 26;- 0 -~Q! 23:1_ _ "'-~~ __ ~ ~~~=--=-_ -65.5+ 2?] 
-~----_,~~6~ ___ ' __ ~1 F154.5 __ _6~ __ " 0 ___ 4~L_~Q:.~ _____ _ 47.5 19.9 44.5 18.6 
327i 30 F' 156. 12: 0 43.5 i 17.9 45 18.5 48.5 19.9 
----~!8T 41 F 155.5 -~'_~-=:?_1:-" 1 89.7r37.~ 89.7 37.1 90.02 37.2 
1-- __ ~2~L 44 F • 'c~.. __ ~\ ___ 9 83! 31.6 83.5 31.8 84 32 
1 __ ~~()L__ 43 F f..- 157.5 14 P 76.5 1," 31 _ _ 79
1 
32 79.3 32.2 
l~if~ ~i ~~!+:~- ~i ! --:! ~;~ ~ .-~ ~ 6~~I~~t 7~~ci:~ 










mt~-gl· ,-: 339~1 i_ 155 
340 1 431F i 152 . ..--! --t---,,- -. .. L_--,-_ 
34~1 __ 6.1lf.___ . 1 __ 1~ ... ~ __ _ 
342' 321F ! 156 .. -1 1 ____ ,.- +-1 _.........::..:::..=. 
343' 32 M I 166 .. ~ __ , " .. , ,J .. _ .. ___ ~ __ , .. 
344' 32 M i 167 l-. _._ . . c_._.........::..::-'.-
. 345' 31 M ,1._~6 
34S.~ ___ ._~~ L __ 158 
347 37 : 16·-,-9-+------
3481 46 F ,.; 59 
. 349 i- - 27 M"-'-'- T~1" 
... _-\- -, .j .. --_._-
350: 30 F 157 




8 1 2' 
'-177- 2" 
o. 1 
_~ 0, _ 1._. __ .• __ . ___ I 





31 --_._ .. __ .. --- .. --.-.+. 
16! 2: -_ .. -.+._-- -.~ '._-'---f 
19 3: -13 t-·- ,--_. -0; 
___ ,.,i_ .. ___ ,...... _ • 
6; O' 
1 51.5J . ~!:2-52r 2!~~ ... ______ r---c-.~3I 21J! 
Q . ... _._!51 t. .,_~~ _ ... _ .----.~!t _?!:2 5?:!5 J ~~:2.. 
o . 96' 35.1 96.5 I 35.3 99.2: 35.6' 
. -- ,,'---' .-.-. --- -1' .. - .. " ·----1··· .. ··-",,_· . l. '---
O'___.____6.~l . ?6:4 _,_. __ .. 65.5L _?~:~ 67 j 29.8 
o 45' 21.9 53; 22.1 54; 22.5 
.9. --.----- --~ ... 46,~! ~Q,I ___ _ 46.§t.~~~?_o.? 1=__ _ ..~~.5r .. -21 
.1 ______ . ___ §~:~; ?~,~_ . __ ~L_~~~ ___ ~Q:05+ 2<4:~ 
.. C! ___ ."._,, __ .61}) ._2!5:.~ 6~~t._.,, __ 2Z 6!51 ... 26.:! 
o 83.4 ~ 24.1 84 24.3 64.5 i 24.4 
"'- .----.. ,,- ... ---- - ... "".- -----,,- --';;-1"""- ,,-,,-+ --
0 __ . _ .. ,, __ §_5.4. 1~,:9 ---56t-,,?9.:1 5~.5j . 2Q.:~ 
1- - ~~il~}~ ····-··~F~tl- ~ii; . ~H 
. i ~~-6~.8'·~§.~ .---- .. .. 62~3\-·~.?I_~ ~3:1r "~.~ 
o 73.4 25.1 74.5 25.5 76, 25.5 











ASSESSMENTS - PASSIVE CONTROL GROUP 
COMMENCEMENT END OF INTERV 3MTH FOLLOW-UP 
f-:-:----
COAl 'SIBOQ POMS COAl SIBOQ POMS COAl ISIBOQ POMS Sub No 
101 225.5 37 35 296.71 39 42 219.41 36 46 
102 238.9 33 72 "2541 36 64 267.4! 30 52 
103 80.6 49 65 160.7 38 75 176 32 82 
104 73.6F56 41 177.6 66 29 121 51 33 
105 12 54 60 101 69 29 36.8 52 52 
106 75.3! L- 41 77 88.81 ~73 133.9 40 75 
107 140.7 27 79 328.7J~_ 68 413.7 38 63 
108 170.61 34 102 2011 3796 169 39 115 
109 42.9 57. 47 30.81 65 47 471 56 54 
110 154.3 47 42 195.8i 51 57 218.9 43 42 
111 189.8 41 : 100 242 27 89 143.3 26 77 
112 56.3 6.9 26 89.8 67 35 112 64 49 
113 75, 62 22 87.8 69 23 208 43 28 
114 34.8 67 44 14.3 68 37 136 56 34 
115 ___ ??Q:~~ .... )} .. __ 1~ 201 45. 57 68.9 56 45 _._--- '------- .-.-- ._._ .. ] -- .- -' ... _--_._- --~ 
.. 240 36 37 116 __ ,132.4L .. _~~ _ ... _~!. .2~~~, -----~~H.---f_l - 117 79.5i 58! 47 1--- 162 54 66 r--""-'-' ... ~ .. -139.2T-""···34l79 ... . . I- - - - -. -- -. . ". .. -- c··_· .-- ~37~~t_ ~§L~ 118 45.8! 40! 24 r---'--- 1191 ~6L_3!J 434.31 1ii " '114 ~ .- .. , -. 119 432[ 19 119 --_._= r·------·- c.....-··-·-·r ----·r-·-·-·-- -.---
120 5 61 i 44 0, 67; 36 112.6 59 54 ---_ ... 1---- ._, .. _.-.,.. .. ,.-.--:=: 
-·~3_6jt_.'J~-r~=~~~ 329.5 40 80 121 273.2 391 73 
-'122 - 106.5T·----S'61 --24 -_ ....... 147! 52, 44 r 270 32 1 62 
123 r-----+- -.- --... _ .. - -~-Pji[=·~~2.~L _~=)~ .. ~.-~--
_, __ ::-:;::-___ ._=.1-___
'--- .. ,~.~ 
. 30~~~1 _~3~±~:=-·;~ 1--.. ·· .. _ .. · ... - . __ ~?l-. __ ~Ql-- 82 124 107.91 551 53 .. _1!~-=a.J __ 51L .. 77 ----- 1---'-'''- -.---.-C-~--:t'-,---.. ----- ~--, 
125 191.61 361 104 169.6; ___ ~~+ ___ 67 144.7. 50 48 
-126 
1-__ 
187 j=·;!~F=-..?~ ~Ti.{~+ --·-.~~L=~:·~~ 
-----
168.3' 431-61 ---- ~'-'--' -- ---~-·---r----127 ___ 13?:.8 .__ ~1. ~_, _51? 49.8 1 61, 36 ---"" ---- _ .. - .--... _- .. '-' -- ... r--'-
128 - ~~f~i1=-~~ 344.9~ 1 41 417.9 44 47 129 164.8 --s2 ---52 46 63 42 ~30 __ ~~9. ____ ~.1 .... ___ 1~ --~-~"--~r--~ 
~31 .~I~\~_ ==~~l~'''-'~f 
~-. ,"'-
-. - ~~~l- ---~~~.- ~~ 
... _ .. -
415.9L- 18 88 r·_ .. --.... ·- . -- r--- --268 39 64 132 
'-'133 ~~ 2~~~71 
--_ .. _--it 1=93 210.6 37 89 134 r--14~~t_=--ts, '-~-~~ r~----- ."-88.:..5-~ ___ 54 ---:~ -- 127. 42 108 - .. --~- 1---'--- -. 
135 __ ~QJJ- .. _1.~+_ .. __ 70 223 61 69 I----~ r-.-------,-,-- ... -. --il------··- _._-_._-- .. ~ 39 92 136 3~11'~--;~l~=~~ .--~~~----~}~ ~~ 137 -'"-'- r------ -'209.8 52 50 
138 
. +------t----·-,-::..= 





233.7· 36 79 37.8 1 32 74 
140 410.9 58 45 362'----54
1 
- 66 - 322.7 59 64 
141 119.9 67 33 174t--571 78 246 28 ' 82 
142 89 50 25 75.41.---'511 25 61 57 27 
143 284.1 37 80 244 39 89 286 32 87 
144 74 63, 95 76.2 66 34 85 59 43 
145 317.2 21 96 305 24 - 86 297 25 92 
146 95 -43" ~---. 172.9i --48 i--- 194 42 82 57 74 
147 358.2 34, 87 
--'-"--. '385.1..... 42 39 316.2 43 92 
148 78.6 42 49 "176.2 38 71 137 43 64 
149 394 32 38 f----- 172:3" ----~ - 62 254 46 63 51 __ :!L-___ -------
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ASSESSMENTS - ACTIVE CONTROL GROUP 
COMMENCEMENT END OF INTERV 3MTH FOLLOW-UP 
Sub No COAl SIBOQ POMS COAl SIBOQ I POMS COAl SIBOQ POMS 
201 ___ 1921 _~ ___ ~7 ___ --~~---'!U-- 92 466 13 94 
202 259.6 J>~ ___ ~ r- ~ ____ ~ ____ 49 188.6; 51 i 36 
203 471 i 30 65 326.91 20; 62 314.9 25 60 
204 138.4 60 32 88.41 591 40 101 64 33 
205 103.3 60 1 50 81.41 3gr-75 -- 59 46 68 
206 121 _ I 68 32 111 69 _ 27 64.5 62 40 











ASSESSMENTS - EXPERIMENTAL GROUP 
COMMENCEMENT END OF INTER~ 3MTH I FOLLOW-UP 
Sub No CDAI SIBDQ POMS CDAll SIBDQ i POMS CDAI SIBDQ POMS 
301 510.5 201 94 414.1 i 26 78 325.8 39 70 
302 74.7' 57 36 157.7 54 1 49 255.2 38 53 
303 205.2 37 78 228.2i 32 76 196 57 55 
304 211.8 37 51 204 41' 47 172.2 53 43 
305 382.9 30 69 214, 37 76 165.6 47 59 
306 339.6 • 63 33 39.7 69 32 13.7 67 35 
307 293.9 451 70 47.9 54 57 82.9 55 30 
308 121 39 4'j 19 66 49 37.5' 60 73 
309 321.2 30 67 188.9 40 56 167 35 38 
310 414.9 49 70 137 35 76 91.9 41 73 
311 313 331 46 342 [ 481 56 369.91 51 64 
312 224.2 -I 49 -:i9~~- :~ = :~ 84.1 'I 36 38 313 297.91 '-41 ~-96 --- '-... 230 53 37 
314 133.11 46 56 133.9. 55. 49 136.1 49 89 
1---.• 
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r----- 1-'188.31 42 --- 60 
c------. -.. - ...... --~ ..... -- _._._.j------- ---
337 327.6 65i 40 9.6' 65i 46 78.6 58 45 
338 
--_ .. _ ..... _-:;;;-: _ .. _---
~:r--~i ~-E 132.81 47 68 437.9 29[ 94 339 286· 33 75 -- 215.2 39 77 --
340 427.2 32 1 101 75.8 37 84 
341 226.6 40 70 113 49 92 82.9 53j 86 -
342 468.9 37 50 267.8 49 29 220 51 28 -
343 218.8 45 57 187.2 47 57 145 49 55 





148 109.21 541 43 68 32 
-------c-::' -38f ear-V 1----_. 
L... ___ ------
346 17.9 69 25 ._-_.-:-:::: 
-171.9 ~-_ 3~ 79 
-.- r-341.9 --1-8 67 347 79.9 56 49 
348 339.9 181 91 
.. - 27 -1ST-rob 241 27 94 
~49 ~4 3IJ=-116 - ---3T--fo5 180 35 99 
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COMMENCEMENT END OF INTERVEN 3 MTH FOLLOW-LIP 
Sl.i-b No CFBC i CESR: CHCT EFBC i EESR ~ EHCT FFBC! FESR FHCT 
~_ "101 c----9.S'----19T---tf33 ---11-.4,-----23 --O~5 r-1 fai-31- 0.35 
102 13.5 141 0.42 14.7, 15 0.45 15.7 16 0.46 
-- 103 16.2 1 0.49 16.1 2 0.49 16.3 6 0.4 
104 14.2 7 0.43 15.2 18 0.44 13.7 8 0.42 
105 12.9 11 0.41 13.3 2" 0.41 13.8 4 0.42 
106 1~~ .. .1 0.41 13.~+_ 8, 0.39 13.~ 5_~ 
f-------~! _. __ l1.~L. __ ~~ __ -0·Z_1 f- __ .1~:~L-.--~~.;..--Jl-=~~ f-. _11J.L_ .. __ ~~-C!:~ 
108 9.4 1 43 0.31 8.71 46. 0.27 " ~J.~~~.....Q~ 
1--. 109 7.8 24 0.28 7.9 21 i 0.25 7.9 112 9~ 
110 11.7 60 0.38 11.6! 44 0.35 11.8 36 0.36 
111 13.7 3 0.44 13.5 7' 0.4 12.9 7i 0.38 





















311 12.1 i 52 0.39 12A 52 0.39 10.9 82 0.36 
312 12.6 211 0.38 12.8 17 OA1 12.6 28 0.38 
313 15 16 OA7 12.7 14 OA 12.7 34 0.38 











COMMENCEMENT END OF INTERVENTION 3 MONTH FOLLOW-UP 
I . -~--'-T-' -; "-'r : .--- I .- 1 :---- -'-r . T I I ----T 
S. ub No_ rgJ!~~J C~~c L Cmag CTBR CAL! ~ CA~!1 ._~i!on _~ Ecal~ : .. E_mag liPBR : EALT: EA Pch_ ~",n ~ Feale I Fmag 1 FTBR rA.~ +£~~-" 
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116 7 2.37 1 0.78, 7 4 41 6: 2.37 0.72! 4 12 94 6i 2.3 0.76 12 14' 92 
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'131 -- 2.37 
---~- . 
.. ... -..... . .+-=-=~-.. -. I ... 
=-!~l = ~1~~ Hn~ ~:E ~it3t ~H --~]t~~E 
~~: 1~j- a~Lj'~~ ~~i~~] '. 1~~--~t~~~ 
7: 2.32 
23Q -_.~.~L_~!L~8..s --.~L-~1.. 136 .. ~~_ ... .?57. 
23~. 12L1:.52LgJ5. _ ~1.2. . 152 _~1._.?,43 
=iii-~ ;i~~t~ijf- ~r -ijii-~:~rn~ 
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236 8: 2.26' 0.77 13 11' 61 7i 2.19 
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